OWENS & MINOR INC/VA/ (Form: 10-K, Received: 02/23/2022 16:43:48)

Execution Version Error! Unknown document property name. AMENDMENT NO. 1 TO CREDIT AGREEMENT THIS AMENDMENT NO. 1 TO CREDIT AGREEMENT (this “Agreement”), dated as of [●] (the “Amendment Effective Date”), is entered into among OWENS & MINOR DISTRIBUTION, INC., a Virginia corporation (“Distribution”), OWENS & MINOR MEDICAL, INC., a Virginia corporation (“Medical”), BARISTA ACQUISITION I, LLC, a Virginia limited liability company (“Barista I”), BARISTA ACQUISITION II, LLC, a Virginia limited liability company (“Barista II”), O&M HALYARD, INC., a Virginia corporation (“O&M Halyard”), BYRAM HEALTHCARE CENTERS, INC., a New Jersey Corporation (“Byram”, and together with Distribution, Medical, Barista I, Barista II and O&M Halyard, the “Borrowers”), OWENS & MINOR, INC., a Virginia corporation (the “Parent”), the Guarantors, the Lenders and BANK OF AMERICA, N.A., as administrative agent (or any of its designated branch offices or affiliates, in such capacity, the “Administrative Agent”). RECITALS WHEREAS, the Borrowers, the Lenders, and the Administrative Agent, have entered into that certain Credit Agreement dated as of March 10, 2021 (as amended, modified, extended, restated, replaced, or supplemented from time to time, the “Credit Agreement”); and WHEREAS, certain loans and/or other extensions of credit (the “Loans”) under the Credit Agreement denominated in Sterling, Canadian Dollars, Australian Dollars, Yen, and Euros (collectively, the “Impacted Currencies”) incur or are permitted to incur interest, fees, commissions or other amounts based on the London Interbank Offered Rate as administered by the ICE Benchmark Administration (“LIBOR”) in accordance with the terms of the Credit Agreement; WHEREAS, applicable parties under the Credit Agreement have determined in accordance with the Credit Agreement that LIBOR for the Impacted Currencies should be replaced with a successor rate in accordance with the Credit Agreement and, in connection therewith, the Administrative Agent has determined that certain conforming changes are necessary or advisable; WHEREAS, in addition to making certain conforming changes necessary to implement a successor rate for the Impacted Currencies, the Borrowers desire to make certain additional amendments to the Credit Agreement as set forth below; NOW, THEREFORE, in consideration of the premises and the mutual covenants contained herein, and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto agree as follows: 1. Defined Terms. Capitalized terms used herein but not otherwise defined herein (including on any Appendix attached hereto) shall have the meanings provided to such terms in the Credit Agreement, as amended by this Agreement. 2. Amendments. (i) Notwithstanding any provision of the Credit Agreement or any other document related thereto (the “Loan Documents”) to the contrary, the parties hereto hereby agree that the terms set forth on Appendix A shall apply solely to the Impacted Currencies. (ii) clause (a) of the definition of “Eurocurrency Rate” in Section 1.01 of the Credit Agreement is hereby amended and restated in its entirety as follows:

2 Error! Unknown document property name. (a) denominated in a LIBOR Quoted Currency, the rate per annum equal to the London Interbank Offered Rate as administered by ICE Benchmark Administration (or any other Person that takes over the administration of such rate for such currency for a period equal in length to such Interest Period) (“LIBOR”), as published on the applicable Bloomberg screen page (or such other commercially available source providing such quotations as may be designated by the Administrative Agent from time to time) at approximately 11:00 a.m. (London time) two (2) Business Days prior to the commencement of such Interest Period, for deposits in the relevant currency, with a term equivalent to such Interest Period, (iii) Section 2.07(c) of the Credit Agreement is hereby amended and restated in its entirety as follows: (c) Swing Line Loans. The Borrowers shall repay each Swing Line Loan in full no later than ninety (90) days after such loan is made. For the avoidance of doubt, to the extent provisions in the Credit Agreement apply to the Impacted Currencies and such provisions are not specifically addressed by Appendix A, the provisions in the Credit Agreement shall continue to apply to the Impacted Currencies. 3. Conflict with Loan Documents. In the event of any conflict between the terms of this Agreement and the terms of the Credit Agreement or the other Loan Documents, the terms hereof shall control. 4. Conditions Precedent. This Agreement shall become effective upon receipt by the Administrative Agent of counterparts of this Agreement, properly executed by the Borrowers, each Lender, each Guarantor and the Administrative Agent. 5. Payment of Expenses. The Borrowers agree to reimburse the Administrative Agent for all reasonable fees, charges and disbursements of the Administrative Agent in connection with the preparation, execution and delivery of this Agreement, including all reasonable fees, charges and disbursements of counsel to the Administrative Agent (paid directly to such counsel if requested by the Administrative Agent). 6. Miscellaneous. (a) The Loan Documents, and the obligations of the Borrowers and the Guarantors under the Loan Documents, are hereby ratified and confirmed and shall remain in full force and effect according to their terms. This Agreement is a Loan Document. (b) The Borrowers and each Guarantor (i) acknowledges and consents to all of the terms and conditions of this Agreement, (ii) affirms all of its obligations under the Loan Documents and (iii) agrees that this Agreement and all documents executed in connection herewith do not operate to reduce or discharge its obligations under the Loan Documents, (iv) agrees that the Collateral Documents continue to be in full force and effect and are not impaired or adversely affected in any manner whatsoever, (v) confirms its grant of security interests pursuant to the Collateral Documents to which it is a party as Collateral for the Obligations, and (vi) acknowledges that all Liens granted (or purported to be granted) pursuant to the Collateral Documents remain and continue in full force and effect in respect of, and to secure, the Obligations. Each Guarantor hereby reaffirms its obligations under the Guaranty and agrees that its obligation to guarantee the Obligations is in full force and effect as of the date hereof.

3 Error! Unknown document property name. (c) The Borrowers and each Guarantor represents and warrants that: (i) This Agreement has been duly executed and delivered by such Person, and constitutes a legal, valid and binding obligation of such Person, enforceable against it in accordance with the terms hereof, except as such enforceability may be limited by Debtor Relief Laws and by general principles of equity. (ii) The execution and delivery by such Person of this Agreement and performance by such Person of this Agreement have been duly authorized by all necessary corporate or other organizational action, and do not and will not (I) contravene the terms of any of such Person’s Organization Documents, (II) conflict with or result in any breach or contravention of, or require any payment to be made under (x) any Contractual Obligation exceeding the Threshold Amount to which such Person is a party or affecting such Person or the properties of such Person or any of its Subsidiaries or (y) any material order, injunction, writ or decree of any Governmental Authority or any arbitral award to which such Person or its property is subject, (III) result in the creation of any Lien (other than under the Loan Documents) or (IV) violate any material Law; except (in the case of clauses (II) and (IV)), to the extent that such conflict, breach, contravention, payment or violation could not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect. (d) This Agreement may be in the form of an electronic record (in “.pdf” form or otherwise) and may be executed using electronic signatures, which shall be considered as originals and shall have the same legal effect, validity and enforceability as a paper record. This Agreement may be executed in as many counterparts as necessary or convenient, including both paper and electronic counterparts, but all such counterparts shall be one and the same Agreement. For the avoidance of doubt, the authorization under this paragraph may include, without limitation, use or acceptance by the Administrative Agent of a manually signed Agreement which has been converted into electronic form (such as scanned into “.pdf” format), or an electronically signed Agreement converted into another format, for transmission, delivery and/or retention. (e) Any provision of this Agreement held to be illegal, invalid or unenforceable in any jurisdiction, shall, as to such jurisdiction, be ineffective to the extent of such illegality, invalidity or unenforceability without affecting the legality, validity or enforceability of the remaining provisions hereof and the illegality, invalidity or unenforceability of a particular provision in a particular jurisdiction shall not invalidate or render unenforceable such provision in any other jurisdiction. (f) The terms of the Credit Agreement with respect to governing law, submission to jurisdiction, waiver of venue and waiver of jury trial are incorporated herein by reference, mutatis mutandis, and the parties hereto agree to such terms. [remainder of page intentionally left blank]

[Signature Page to Amendment] Each of the parties hereto has caused a counterpart of this Agreement to be duly executed and delivered as of the date first above written. BORROWERS: OWENS & MINOR DISTRIBUTION, INC., as a Borrower By: Name: Michael W. Lowry Title: Senior Vice President and Chief Financial Officer OWENS & MINOR MEDICAL, INC., as a Borrower By: Name: Jonathan Leon Title: Chief Financial Officer BARISTA ACQUISITION I, LLC, as a Borrower By: Name: Jonathan Leon Title: President and Chief Financial Officer BARISTA ACQUISITION II, LLC, as a Borrower By: Name: Jonathan Leon Title: President and Chief Financial Officer O&M HALYARD, INC., as a Borrower By: Name: Michael W. Lowry Title: Chief Financial Officer BYRAM HEALTHCARE CENTER, INC., as a Borrower By: Name: Perry Bernocchi Title: Chief Executive Officer and President DocuSign Envelope ID: A2430D2C-C031-43F1-AAA4-4E718101E1FE

[Signature Page to Amendment] GUARANTORS: OWENS & MINOR, INC., as a Guarantor By: Name: Jonathan Leon Title: Senior Vice President and Corporate Treasurer OWENS & MINOR INTERNATIONAL LOGISTICS, INC., as a Guarantor By: Name: Jonathan Leon Title: Chief Financial Officer O&M BYRAM HOLDINGS, GP, as a Guarantor By: Barista Acquisition I, LLC and Barista Acquisition II, LLC Its: Partners By: Name: Jonathan Leon Title: President and Chief Financial Officer BYRAM HOLDINGS I, INC., as a Guarantor By: Name: Perry Bernocchi Title: Chief Executive Officer and President OWENS & MINOR HEALTHCARE SUPPLY, INC., as a Guarantor By: Name: Jonathan Leon Title: Chief Financial Officer MEDICAL ACTION INDUSTRIES, INC., as a Guarantor By: Name: Jonathan Leon Title: Vice President and Treasurer DocuSign Envelope ID: A2430D2C-C031-43F1-AAA4-4E718101E1FE

[Signature Page to Amendment] AVID MEDICAL, INC., as a Guarantor By: Name: Jonathan Leon Title: Vice President and Treasurer HALYARD NORTH CAROLINA, LLC, as a Guarantor By: Name: Michael W. Lowry Title: Senior Vice President and Chief Financial Officer DocuSign Envelope ID: A2430D2C-C031-43F1-AAA4-4E718101E1FE

[Signature Page to Amendment No. 1 to Credit Agreement] Error! Unknown document property name. ADMINISTRATIVE AGENT: BANK OF AMERICA, N.A., as Administrative Agent By: Name: Title:

[Signature Page to Amendment No. 1 to Credit Agreement] Error! Unknown document property name. LENDERS: BANK OF AMERICA, N.A., as a Lender By: Name: Title:

[Signature Page to Amendment No. 1 to Credit Agreement] Error! Unknown document property name. [_], as a Lender By: Name: Title:

Error! Unknown document property name. Appendix A TERMS APPLICABLE TO ALTERNATIVE CURRENCY LOANS 1. Defined Terms. The following terms shall have the meanings set forth below: “Administrative Agent’s Office” means, with respect to any currency, the Administrative Agent’s address and, as appropriate, account specified in the Credit Agreement with respect to such currency, or such other address or account with respect to such currency as the Administrative Agent may from time to time notify the Parent and the Lenders. “Alternative Currency” means each of the following currencies: Sterling, Canadian Dollars, Australian Dollars, Yen, and Euros. “Alternative Currency Daily Rate” means, for any day, with respect to any extension of credit under the Credit Agreement denominated in Sterling, the rate per annum equal to SONIA determined pursuant to the definition thereof plus the SONIA Adjustment; provided, that, if any Alternative Currency Daily Rate shall be less than zero, such rate shall be deemed zero for purposes of this Agreement. Any change in an Alternative Currency Daily Rate shall be effective from and including the date of such change without further notice. “Alternative Currency Daily Rate Loan” means a Loan that bears interest at a rate based on the definition of “Alternative Currency Daily Rate.” All Alternative Currency Daily Rate Loans must be denominated in an Alternative Currency. “Alternative Currency Loan” means an Alternative Currency Daily Rate Loan or an Alternative Currency Term Rate Loan, as applicable. “Alternative Currency Term Rate” means, for any Interest Period, with respect to any extension of credit under the Credit Agreement: (a) denominated in Euros, the rate per annum equal to the Euro Interbank Offered Rate (“EURIBOR”), as published on the applicable Reuters screen page (or such other commercially available source providing such quotations as may be designated by the Administrative Agent from time to time) on the day that is two TARGET Days preceding the first day of such Interest Period with a term equivalent to such Interest Period; (b) denominated in Japanese Yen, the rate per annum equal to the Tokyo Interbank Offer Rate (“TIBOR”), as published on the applicable Reuters screen page (or such other commercially available source providing such quotations as may be designated by the Administrative Agent from time to time) on the day that is two Business Days preceding the first day of such Interest Period (or such other day as is generally treated as the rate fixing day by market practice in such interbank market, as determined by the Administrative Agent; provided that, to the extent such market practice is not administratively feasible for the Administrative Agent, then such date shall be such other day as otherwise reasonably determined by the Administrative Agent) with a term equivalent to such Interest Period; (c) denominated in Australian Dollars, the rate per annum equal to the Bank Bill Swap Reference Bid Rate (“BBSY”), as published on the applicable Reuters screen

Error! Unknown document property name. page (or such other commercially available source providing such quotations as may be designated by the Administrative Agent from time to time) on the day that is two Business Days preceding the first day of such Interest Period (or such other day as is generally treated as the rate fixing day by market practice in such interbank market, as determined by the Administrative Agent; provided that, to the extent such market practice is not administratively feasible for the Administrative Agent, then such date shall be such other day as otherwise reasonably determined by the Administrative Agent) with a term equivalent to such Interest Period; and (d) denominated in Canadian Dollars, the rate per annum equal to the Canadian Dollar Offered Rate (“CDOR”), as published on the applicable Reuters screen page (or such other commercially available source providing such quotations as may be designated by the Administrative Agent from time to time) (in such case, the “CDOR Rate”) on the day that is two Business Days preceding the first day of such Interest Period (or such other day as is generally treated as the rate fixing day by market practice in such interbank market, as determined by the Administrative Agent; provided that, to the extent such market practice is not administratively feasible for the Administrative Agent, then such date shall be such other day as otherwise reasonably determined by the Administrative Agent) with a term equivalent to such Interest Period; provided, that, if any Alternative Currency Term Rate shall be less than zero, such rate shall be deemed zero for purposes of this Agreement. “Alternative Currency Term Rate Loan” means a Loan that bears interest at a rate based on the definition of “Alternative Currency Term Rate.” All Alternative Currency Term Rate Loans must be denominated in an Alternative Currency. “Applicable Authority” means, with respect to any Alternative Currency, the applicable administrator for the Relevant Rate for such Alternative Currency or any governmental authority having jurisdiction over the Administrative Agent or such administrator. “Applicable Rate” means the Applicable Rate, as defined in the Credit Agreement. “Base Rate” means the Base Rate, as defined in the Credit Agreement. “Base Rate Loans” means a Loan that bears interest at a rate based on the Base Rate. “Borrowing” means a Borrowing, as defined in the Credit Agreement. “Business Day” means any day other than a Saturday, Sunday or other day on which commercial banks are authorized or required to close under the laws of, or are in fact closed in, the state where the Administrative Agent’s Office is located; provided that (a) if such day relates to any interest rate settings as to an Alternative Currency Loan denominated in Euro, any fundings, disbursements, settlements and payments in Euro in respect of any such Alternative Currency Loan, or any other dealings in Euro to be carried out pursuant to this Agreement in respect of any such Alternative Currency Loan, means a Business Day that is also a TARGET Day; (b) if such day relates to any interest rate settings as to an Alternative Currency Loan denominated in (i) Sterling, means a day other than a day banks are

Error! Unknown document property name. closed for general business in London because such day is a Saturday, Sunday or a legal holiday under the laws of the United Kingdom, (ii) Japanese Yen, means a day other than when banks are closed for general business in Japan, (iii) Australian Dollars, means a day other than when banks are closed for general business in Australia and (iv) Canadian Dollars, means a day other than when banks are closed for general business in Canada; and (c) if such day relates to any fundings, disbursements, settlements and payments in a currency other than Euro in respect of an Alternative Currency Loan denominated in a currency other than Euro, or any other dealings in any currency other than Euro to be carried out pursuant to this Agreement in respect of any such Alternative Currency Loan (other than any interest rate settings), means any such day on which banks are open for foreign exchange business in the principal financial center of the country of such currency. “Committed Loan Notice” means a Committed Loan Notice, as defined in the Credit Agreement, and such term shall be deemed to include the Committed Loan Notice attached hereto as Exhibit A. “Conforming Changes” means, with respect to the use, administration of or any conventions associated with SONIA, EURIBOR, TIBOR, BBSY, CDOR or any proposed Successor Rate for any currency, any conforming changes to the definitions of “SONIA”, “EURIBOR”, “TIBOR”, “BBSY”, “CDOR”, “Interest Period”, timing and frequency of determining rates and making payments of interest and other technical, administrative or operational matters (including, for the avoidance of doubt, the definition of “Business Day”, timing of borrowing requests or prepayment, conversion or continuation notices, the applicability of breakage provisions and length of lookback periods) as may be appropriate, in the discretion of the Administrative Agent, to reflect the adoption and implementation of such applicable rate(s) and to permit the administration thereof by the Administrative Agent in a manner substantially consistent with market practice for such currency (or, if the Administrative Agent determines that adoption of any portion of such market practice is not administratively feasible or that no market practice for the administration of such rate for such currency exists, in such other manner of administration as the Administrative Agent determines is reasonably necessary in connection with the administration of this Agreement and any other Loan Document). “Dollar” and “$” mean lawful money of the United States. “Dollar Equivalent” means the Dollar Equivalent, as defined in the Credit Agreement. “Eurocurrency Rate” means Eurocurrency Rate, as defined in the Credit Agreement. “Eurocurrency Rate Loans” means a Loan that bears interest at a rate based on the Eurocurrency Rate. “Interest Payment Date” means, (a) as to any Alternative Currency Daily Rate Loan, the last Business Day of each month and the applicable maturity date set forth in the Credit Agreement and (b) as to any Alternative Currency Term Rate Loan, the last day of each Interest Period applicable to such Loan; provided, however, that if any Interest Period for an Alternative Currency Term Rate Loan exceeds three months, the respective dates that fall every three months after the beginning of such Interest Period shall be Interest Payment Dates.

Error! Unknown document property name. “Interest Period” means as to each Alternative Currency Term Rate Loan, the period commencing on the date such Alternative Currency Term Rate Loan is disbursed or converted to or continued as an Alternative Currency Term Rate Loan and ending on the date one, three or six months thereafter (in each case, subject to availability for the interest rate applicable to the relevant currency), as selected by the Borrowers in each Committed Loan Notice, or twelve months or any other period thereafter as selected by the Borrowers and consented to by each Lender of such Alternative Currency Term Rate Loan; provided that: (a) any Interest Period that would otherwise end on a day that is not a Business Day shall be extended to the next succeeding Business Day unless, in the case of an Alternative Currency Term Rate Loan, such Business Day falls in another calendar month, in which case such Interest Period shall end on the next preceding Business Day; (b) any Interest Period pertaining to an Alternative Currency Term Rate Loan that begins on the last Business Day of a calendar month (or on a day for which there is no numerically corresponding day in the calendar month at the end of such Interest Period) shall end on the last Business Day of the calendar month at the end of such Interest Period; and (c) no Interest Period shall extend beyond the Maturity Date. “Relevant Rate” means, with respect to any Loan denominated in (a) Sterling, SONIA, (b) Euros, EURIBOR, (c) Japanese Yen, TIBOR, (d) Australian Dollars, BBSY and (e) Canadian Dollars, CDOR, as applicable. “Required Lenders” means the Required Lenders, as defined in the Credit Agreement, subject to Section 2(g) of this Appendix A. “Scheduled Unavailability Date” has the meaning set forth in Section 2(g) of this Appendix A. “SONIA” means, with respect to any applicable determination date, the Sterling Overnight Index Average Reference Rate published on the fifth Business Day preceding such date on the applicable Reuters screen page (or such other commercially available source providing such quotations as may be designated by the Administrative Agent from time to time); provided however that if such determination date is not a Business Day, SONIA means such rate that applied on the first Business Day immediately prior thereto. “SONIA Adjustment” means, with respect to SONIA, 0.0326% per annum. “Successor Rate” has the meaning set forth in Section 2(g). “TARGET2” means the Trans-European Automated Real-time Gross Settlement Express Transfer payment system which utilizes a single shared platform and which was launched on November 19, 2007. “TARGET Day” means any day on which TARGET2 (or, if such payment system ceases to be operative, such other payment system, if any, determined by the Administrative Agent to be a suitable replacement) is open for the settlement of payments in Euro.

Error! Unknown document property name. “Type” means, with respect to a Loan, its character as a Base Rate Loan, a Daily LIBOR Swingline Loan, a Eurocurrency Rate Loan, an Alternative Currency Daily Rate Loan or an Alternative Currency Term Rate Loan. 2. Terms Applicable to Alternative Currency Loans. From and after the Amendment Effective Date, the parties hereto agree as follows: (a) Alternative Currencies. (i) No Alternative Currency shall be considered a currency for which there is a published LIBOR rate, and (ii) any request for a new Loan denominated in an Alternative Currency, or to continue an existing Loan denominated in an Alternative Currency, shall be deemed to be a request for a new Loan bearing interest at the Alternative Currency Daily Rate or Alternative Currency Term Rate, as applicable; provided, that, to the extent any Loan bearing interest at the Eurocurrency Rate is outstanding on the Amendment Effective Date, such Loan shall continue to bear interest at the Eurocurrency Rate until the end of the current Interest Period or payment period applicable to such Loan unless, in the case of a Loan that bears interest at a daily floating rate, such daily floating rate is no longer representative or being made available, in which case such Loan shall bear interest at the applicable Alternative Currency Rate immediately upon the effectiveness of this Agreement. (b) References to Eurocurrency Rate and Eurocurrency Rate Loans in the Credit Agreement and Loan Documents. (i) References to the Eurocurrency Rate and Eurocurrency Rate Loans in provisions of the Credit Agreement and the other Loan Documents that are not specifically addressed herein (other than the definitions of Eurocurrency Rate and Eurocurrency Rate Loan) shall be deemed to include Alternative Currency Daily Rates, Alternative Currency Term Rates, and Alternative Currency Loans, as applicable. (ii) For purposes of any requirement for the Borrowers to compensate Lenders for losses in the Credit Agreement resulting from any continuation, conversion, payment or prepayment of any Alternative Currency Loan on a day other than the last day of any Interest Period (as defined in the Credit Agreement), references to the Interest Period (as defined in the Credit Agreement) shall be deemed to include any relevant interest payment date or payment period for an Alternative Currency Loan. (c) Interest Rates. The Administrative Agent does not warrant, nor accept responsibility, nor shall the Administrative Agent have any liability with respect to the administration, submission or any other matter related to the rates in the definition of “Alternative Currency Daily Rate”, “Alternative Currency Term Rate” or with respect to any rate that is an alternative or replacement for or successor to any such rate or the effect of any of the foregoing, or of any Conforming Changes. (d) Borrowings and Continuations of Alternative Currency Loans. In addition to any other borrowing requirements set forth in the Credit Agreement: (i) Alternative Currency Loans. Each Borrowing of Alternative Currency Loans, and each continuation of an Alternative Currency Term Rate Loan shall be made upon the Borrower’s irrevocable notice to the Administrative Agent, which may be given by (A) telephone or (B) a Committed Loan Notice; provided that any telephonic notice must be confirmed promptly by hand delivery, telecopy or electronic transmission to the Administrative Agent of a written Committed Loan Notice, appropriately completed and

Error! Unknown document property name. signed by a Responsible Office of the Parent. Each such notice must be received by the Administrative Agent substantially in the form attached hereto as Exhibit A or any other form that may be approved by the Administrative Agent (including any form on an electronic platform or electronic transmission system as shall be approved by the Administrative Agent), (x) in the case of Loans denominated in Alternative Currencies other than Yen, not later than 1:00 p.m. New York City time, four (4) Business Days (or five (5) Business Days in the case of a Special Notice Currency) prior to the requested date of any Borrowing or, in the case of Alternative Currency Term Rate Loans, any continuation, (y) in the case of Loans denominated in Yen, not later than 1:00 p.m. New York City time, five (5) Business Days prior to the requested date of any Borrowing or continuation; provided, however, that if the Borrowers wish to request Alternative Currency Term Rate Loans having an Interest Period other than one, three or six months in duration as provided in the definition of “Interest Period,” the applicable notice must be received by the Administrative Agent not later than 1:00 p.m. New York City time five Business Days (or six Business Days in the case of a Special Notice Currency) prior to the requested date of such Borrowing or continuation of Alternative Currency Term Rate Loans, whereupon the Administrative Agent shall give prompt notice to the Lenders of such request and determine whether the requested Interest Period is acceptable to all of them. Not later than 1:00 p.m. New York City time, four Business Days (or five Business Days in the case of a Special Notice Currency) prior to the requested date of such Borrowing or continuation of Alternative Currency Term Rate Loans, the Administrative Agent shall notify the Borrowers (which notice may be by telephone) whether or not the requested Interest Period has been consented to by all the Lenders. Each Borrowing of or continuation of Alternative Currency Loans shall be in a principal amount of the Dollar Equivalent of $5,000,000 or a whole multiple of the Dollar Equivalent of $1,000,000 in excess thereof. Each Committed Loan Notice (whether telephonic or written) shall specify (i) whether the Borrowers are requesting a Borrowing or a continuation of Alternative Currency Term Rate Loans, (ii) the requested date of the Borrowing or continuation, as the case may be (which shall be a Business Day), (iii) the currency and principal amount of Loans to be borrowed or continued, (iv) the Type of Loans to be borrowed, (v) if applicable, the duration of the Interest Period with respect thereto. If the Borrowers fail to specify a currency in a Committed Loan Notice requesting a Borrowing, then the Loans so requested shall be made in Dollars. If the Borrowers fail to specify a Type of Loan in a Committed Loan Notice or if the Borrowers fail to give a timely notice requesting a continuation, then the applicable Loans shall be made as Base Rate Loans denominated in Dollars; provided, however, that in the case of a failure to timely request a continuation of Alternative Currency Term Rate Loans, such Loans shall be continued as Alternative Currency Term Rate Loans in their original currency with an Interest Period of one (1) month. If the Borrowers request a Borrowing of or continuation of Alternative Currency Term Rate Loans in any such Committed Loan Notice, but fail to specify an Interest Period, it will be deemed to have specified an Interest Period of one month. Except as otherwise specified in the Credit Agreement, no Alternative Currency Loan may be converted into or continued as a Loan denominated in a different currency, but instead must be repaid in the original currency of such Alternative Currency Loan and reborrowed in the other currency. (ii) Conforming Changes. With respect to any Alternative Currency Rate the Administrative Agent will have the right to make Conforming Changes in good faith from time to time and, notwithstanding anything to the contrary herein, in the Credit Agreement or in any other Loan Document, any amendments implementing such Conforming Changes will become effective without any further action or consent of any

Error! Unknown document property name. other party to this Agreement, the Credit Agreement or any other Loan Document; provided, that, with respect to any such amendment effected, the Administrative Agent shall post each such amendment implementing such Conforming Changes to the Borrowers and the Lenders reasonably promptly after such amendment becomes effective. (iii) Committed Loan Notice. For purposes of a Borrowing of Alternative Currency Loans, or a continuation of and Alternative Currency Term Rate Loan, the Borrowers shall use the Committed Loan Notice attached hereto as Exhibit A. (e) Interest. (i) Subject to the provisions of the Credit Agreement with respect to the Default Rate, (x) each Alternative Currency Daily Rate Loan shall bear interest on the outstanding principal amount thereof from the applicable borrowing date at a rate per annum equal to the Alternative Currency Daily Rate plus the Applicable Rate; and (y) each Alternative Currency Term Rate Loan shall bear interest on the outstanding principal amount thereof for each Interest Period at a rate per annum equal to the Alternative Currency Term Rate for such Interest Period plus the Applicable Rate. (ii) Interest on each Alternative Currency Loan shall be due and payable in arrears on each Interest Payment Date applicable thereto and at such other times as may be specified the Credit Agreement. Interest hereunder shall be due and payable in accordance with the terms hereof before and after judgment, and before and after the commencement of any proceeding under any Debtor Relief Law. (f) Computations. All computations of interest for Alternative Currency Loans shall be made on the basis of a year of 365 or 366 days, as the case may be, and actual days elapsed, or, in the case of interest in respect of Alternative Currency Loans as to which market practice differs from the foregoing, in accordance with such market practice. Interest shall accrue on each Alternative Currency Loan for the day on which the Alternative Currency Loan is made, and shall not accrue on an Alternative Currency Loan, or any portion thereof, for the day on which the Alternative Currency Loan or such portion is paid, provided that any Alternative Currency Loan that is repaid on the same day on which it is made shall, subject to the terms of the Credit Agreement, bear interest for one day. Each determination by the Administrative Agent of an interest rate or fee hereunder shall be conclusive and binding for all purposes, absent manifest error. (g) Inability to Determine Rate; Successor Rates. (i) Defined Terms. For purposes of this Section 2(g), those Lenders that either have not made, or do not have an obligation under the Credit Agreement to make, the relevant Loans in the relevant Alternative Currency shall be excluded from any determination of Required Lenders. (ii) Inability to Determine Rates. If in connection with any request for an Alternative Currency Loan or a continuation of any of such Loans, as applicable, (A) the Administrative Agent determines (which determination shall be conclusive absent manifest error) that (x) no Successor Rate for the Relevant Rate for the applicable currency has been determined in accordance with Section 2(g)(iii) and the circumstances under clause (x) of Section 2(g)(iii) or the Scheduled Unavailability Date has occurred with respect to such Relevant Rate (as

Error! Unknown document property name. applicable), or (y) adequate and reasonable means do not otherwise exist for determining the Relevant Rate for the applicable currency for any determination date(s) or requested Interest Period, as applicable, with respect to a proposed Alternative Currency Loan, or (B) the Administrative Agent or the Required Lenders determine that for any reason that the Relevant Rate with respect to a proposed Alternative Currency Loan denominated in a currency for any requested Interest Period or determination date(s) does not adequately and fairly reflect the cost to such Lenders of funding such Alternative Currency Loan, the Administrative Agent will promptly so notify the Borrowers and each Lender. Thereafter, (x) the obligation of the Lenders to make or maintain Loans in the affected currencies, as applicable, shall be suspended in each case to the extent of the affected Alternative Currency Loans or Interest Period or determination date(s), as applicable, in each case until the Administrative Agent (or, in the case of a determination by the Required Lenders described in clause (B) of this Section, until the Administrative Agent upon instruction of the Required Lenders) revokes such notice. Upon receipt of such notice, (A) the Borrowers may revoke any pending request for a Borrowing of, or continuation of Alternative Currency Loans to the extent of the affected Alternative Currency Loans or Interest Period or determination date(s), as applicable or, failing that, will be deemed to have converted such request into a request for a Borrowing of Base Rate Loans denominated in Dollars in the Dollar Equivalent of the amount specified therein and (B) any outstanding affected Alternative Currency Loans, at the Borrower’s election, shall either (1) be converted into a Borrowing of Base Rate Loans denominated in Dollars in the Dollar Equivalent of the amount of such outstanding Alternative Currency Loan immediately upon such election (or deemed election pursuant to the proviso below), in the case of an Alternative Currency Daily Rate Loan or at the end of the applicable Interest Period, in the case of an Alternative Currency Term Rate Loan or (2) be prepaid in full immediately upon such election (or deemed election pursuant to the proviso below), in the case of an Alternative Currency Daily Rate Loan, or, at the end of the applicable Interest Period, in the case of an Alternative Currency Term Rate Loan; provided that if no election is made by the Borrowers (x) in the case of an Alternative Currency Daily Rate Loan, by the date that is three Business Days after receipt by the Borrowers of such notice or (y) in the case of an Alternative Currency Term Rate Loan, by the last day of the current Interest Period for the applicable Alternative Currency Term Rate Loan, the Borrowers shall be deemed to have elected clause (1) above. (iii) Replacement of Relevant Rate or Successor Rate. Notwithstanding anything to the contrary in this Agreement, the Credit Agreement or any other Loan Documents, if the Administrative Agent determines (which determination shall be conclusive absent manifest error), or the Borrowers or Required Lenders notify the Administrative Agent (with, in the case of the Required Lenders, a copy to the Borrower) that the Borrowers or Required Lenders (as applicable) have determined, that: (x) adequate and reasonable means do not exist for ascertaining the Relevant Rate for an Alternative Currency because none of the tenors of such Relevant Rate (including any forward-looking term rate thereof) is available or published on a current basis and such circumstances are unlikely to be temporary; or (y) the Applicable Authority has made a public statement identifying a specific date after which all tenors of the Relevant Rate for an Alternative Currency (including any forward-looking term rate thereof) shall or will no longer be representative or made available, or used for determining the interest rate of loans denominated in such

Error! Unknown document property name. Alternative Currency, or shall or will otherwise cease, provided that, in each case, at the time of such statement, there is no successor administrator that is satisfactory to the Administrative Agent that will continue to provide such representative tenor(s) of the Relevant Rate for such Alternative Currency (the latest date on which all tenors of the Relevant Rate for such Alternative Currency (including any forward-looking term rate thereof) are no longer representative or available permanently or indefinitely, the “Scheduled Unavailability Date”); or (z) syndicated loans currently being executed and agented in the United States, are being executed or amended (as applicable) to incorporate or adopt a new benchmark interest rate to replace the Relevant Rate for an Alternative Currency; or if the events or circumstances of the type described in Section 2(g)(iii)(x), (iii)(y) or (iii)(z) of this Appendix A have occurred with respect to the Successor Rate then in effect, and the Administrative Agent determines in good faith that none of the Successor Rates is available, then, in each case, the Administrative Agent and the Borrowers may amend this Agreement solely for the purpose of replacing the Relevant Rate for an Alternative Currency or any then current Successor Rate for an Alternative Currency in accordance with this Section 2(g)(iii) with an alternative benchmark rate giving due consideration to any evolving or then existing convention for similar credit facilities syndicated and agented in the United States and denominated in such Alternative Currency for such alternative benchmarks, and, in each case, including any mathematical or other adjustments to such benchmark giving due consideration to any evolving or then existing convention for similar credit facilities syndicated and agented in the United States and denominated in such Alternative Currency for such benchmarks, which adjustment or method for calculating such adjustment shall be published on an information service as selected by the Administrative Agent in good faith from time to time in its reasonable discretion and may be periodically updated (and any such proposed rate, including for the avoidance of doubt, any adjustment thereto, a “Successor Rate”), and any such amendment shall become effective at 5:00 p.m. on the fifth Business Day after the Administrative Agent shall have posted such proposed amendment to all Lenders and the Borrowers unless, prior to such time, Lenders comprising the Required Lenders have delivered to the Administrative Agent written notice that such Required Lenders object to such amendment. The Administrative Agent will promptly (in one or more notices) notify the Borrowers and each Lender of the implementation of any Successor Rate. Any Successor Rate shall be applied in a manner consistent with market practice; provided that to the extent such market practice is not administratively feasible for the Administrative Agent, such Successor Rate shall be applied in a manner as otherwise reasonably determined in good faith by the Administrative Agent. Notwithstanding anything else herein or in the Credit Agreement, if at any time any Successor Rate as so determined would otherwise be less than zero, the Successor Rate will be deemed to be zero for the purposes of this Agreement and the other Loan Documents. In connection with the implementation of a Successor Rate, the Administrative Agent will have the right to make Conforming Changes in good faith from time to time and, notwithstanding anything to the contrary herein or in any other Loan Document, any amendments implementing such Conforming Changes will become effective without any further action or consent of any other party to this Agreement; provided that, with respect to

Error! Unknown document property name. any such amendment effected, the Administrative Agent shall post each such amendment implementing such Conforming Changes to the Borrowers and the Lenders reasonably promptly after such amendment becomes effective.

Error! Unknown document property name. Exhibit A FORM OF COMMITTED LOAN NOTICE (Alternative Currency Loans) Date: ___________, _____1 To: Bank of America, N.A., as Administrative Agent and Collateral Agent under the Credit Agreement referred to below Bank of America, N.A. Gateway Village -900 Bldg. 900 W Trade St. Mailcode: NC1-026-06-04 Charlotte, NC 28255-0001 Attn: Patricia Santos Phone: 980-387-3794 Email: patricia.santos@bofa.com Ladies and Gentlemen: Reference is made to that certain Credit Agreement dated as of March 10, 2021 (as may be amended, restated, amended and restated, extended, replaced, refinanced, supplemented or otherwise modified from time to time, the “Credit Agreement”; the terms defined therein being used herein as therein defined) among OWENS & MINOR DISTRIBUTION, INC., a Virginia corporation, OWENS & MINOR MEDICAL, INC., a Virginia corporation, BARISTA ACQUISITION I, LLC, a Virginia limited liability company, BARISTA ACQUISITION II, LLC, a Virginia limited liability company, O&M HALYARD, INC., a Virginia corporation, BYRAM HEALTHCARE CENTERS, INC., a New Jersey Corporation (collectively, the “Borrowers”), OWENS & MINOR, INC., a Virginia corporation (the “Parent”), the other Loan Parties party thereto, BANK OF AMERICA, N.A., as Administrative Agent and Collateral Agent, and each lender from time to time party thereto (collectively, the “Lenders” and individually, a “Lender”), The undersigned hereby requests (select one)2: Indicate: Borrowing, Conversion or Continuation Indicate: Borrower Name Indicate: Requested Amount Indicate: Currency Indicate: Alternative Currency Daily Rate Loan or Alternative Currency Term Rate Loan For Alternative Currency Term Rate Loans Indicate: Interest Period (e.g., 1, 3 or 6 month interest period) 1 Note to Borrower. All requests submitted under a single Committed Loan Notice must be effective on the same date. If multiple effective dates are needed, multiple Committed Loan Notices will need to be prepared and signed. 2 Note to Borrower. For multiple borrowings, conversions and/or continuations, fill out a new row for each borrowing/conversion and/or continuation.

Error! Unknown document property name. The location and number of the applicable Borrower’s account to which funds are to be disbursed is: Bank: ___________________________ ABA #: ___________________________ Account #: ________________________ Account Name: ____________________ [The undersigned hereby certifies that the following statements will be true on the date of the Proposed Borrowing: (A) The representations and warranties contained in Article V of the Credit Agreement or each other Loan Document are true and correct in all material respects on and as of the date of the Proposed Borrowing; provided that, to the extent that such representations and warranties specifically refer to an earlier date, they are true and correct in all material respects as of such earlier date; provided, further that any representation and warranty that is qualified as to “materiality,” “Material Adverse Effect” or similar language is true and correct (after giving effect to any qualification therein) in all respects on such respective dates. (B) No Default exists, or would result from the Proposed Borrowing or from the application of the proceeds therefrom.]3 [The undersigned hereby certifies that the following statements will be true on the date of the Proposed Borrowing: (A) The Specified Representations are true and correct in all material respects on and as of the date of the Proposed Borrowing; provided that, to the extent that such representations and warranties specifically refer to an earlier date, they are true and correct in all material respects as of such earlier date; provided, further that any representation and warranty that is qualified as to “materiality,” “Material Adverse Effect” or similar language is true and correct (after giving effect to any qualification therein) in all respects on such respective dates. (B) No Specified Event of Default exists, or would result from the Proposed Borrowing or from the application of the proceeds therefrom.]4 Delivery of an executed counterpart of this Committed Loan Notice by telecopier or other electronic transmission shall be effective as delivery of an original executed counterpart of this Committed Loan Notice. 3 To include for all Borrowings (other than (x) for a conversion of Loans to the other Type, or a continuation of Eurocurrency Rate Loans or (y) a Credit Extension of Incremental Revolving Commitments in connection with a Limited Condition Transaction for which an LCT Election has been made). 4 To include for all Credit Extension of Incremental Revolving Commitments in connection with a Limited Condition Transaction for which an LCT Election has been made.

Error! Unknown document property name. Very truly yours, OWENS & MINOR, INC., as the Parent By: Name: Title:

[***] – Certain identified information has been excluded from this exhibit because it is both not material and is treated by Company as private or confidential. CONFIDENTIAL EXECUTIVE SEPARATION AGREEMENT & GENERAL RELEASE This Confidential Executive Separation Agreement & General Release (the “Agreement”) is entered into as of the Effective Date (as defined below), by and between Christopher Lowery (“Executive”) and Owens & Minor, Inc. (together with all Related Entities (as defined herein), “O&M” or the “Company”) (Executive and O&M are each referred to herein as a “Party” and, collectively, as the “Parties”) and in light of the following circumstances: WHEREAS, Executive has been employed by and an officer of the Company and/or a Related Entity(ies), most recently as its President – Global Products; WHEREAS, Executive has, at the request of the Company, resigned from his position with the Company effective March 31, 2022 (the “Separation Date”); WHEREAS, this Agreement is a condition precedent to Executive’s continued at will employment through the Separation Date and receipt of severance benefits under the Owens & Minor, Inc. Officer Severance Policy (the “Policy”). NOW, THEREFORE, in consideration of the Parties’ promises and obligations hereunder, and other good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, the Parties agree as follows: 1. Separation Date and Transition Period. a. The Parties intend that Executive’s last day of employment with the Company shall be the Separation Date, and Executive acknowledges and agrees that his employment relationship with the Company will end no later than such date, unless otherwise agreed by the Parties in writing. Executive further acknowledges and agrees to resign as President – Global Products of the Company, and from all other officer, director, employee or other positions with Owens & Minor, Inc. and all Related Entities effective as of the Separation Date or such earlier time as the Company may request, in its sole discretion; provided, however, that such earlier resignation shall not impact Executive’s rights under this Agreement or any existing change in control or similar agreement. For purposes of this Agreement, “Related Entities” means Owens & Minor, Inc.’s subsidiary and affiliated entities and each of their predecessors. b. Executive shall remain employed by the Company on an at‐will basis as an employee of the Company through the Separation Date (the “Transition Period”). During the Transition Period, Executive will continue to perform his customary duties, or such other duties as the Company may direct, and will facilitate the transition of Executive’s responsibilities to others within the Company as may be requested by O&M. Executive’s employment by the Company during the Transition Period shall be at will, meaning that either the Company or the Executive may end the employment relationship at any time and for any lawful reason. On or within five (5) days after the Separation Date, Executive agrees to execute the Release of Claims attached hereto as Exhibit A and incorporated herein by this reference (the “Subsequent Release”). c. Executive understands and acknowledges that some matters that fell under Executive’s responsibility in his position with the Company may be ongoing after the Separation Date. Accordingly, Executive agrees that for a period of twelve (12) months after the Separation Date Executive will

Page 2 of 15 cooperate and make himself reasonably available to Company representatives to respond to questions regarding Executive’s experience with and knowledge about the Company. Additionally, Executive agrees that he will assist O&M, as reasonably requested by the Company, in the case of any litigation, regulatory inquiry, audits, or other such matters. d. In the event that Executive abandons his employment or is terminated by the Company for Cause (as that term is defined in the Policy) prior to the Separation Date, Executive shall not be eligible to receive, and the Company shall have no obligation to provide, any of the Separation Benefits set forth in Section 3 of this Agreement. The Company may elect to relieve Executive of his duties prior to the Separation Date, but allow Executive to remain employed until the Separation Date and remain eligible for the Severance Benefits and other compensation and benefits accrued through the Separation Date. e. Executive represents and warrants that Executive has complied with the Company’s Code of Honor and compliance policies and that Executive is not aware of any material violation of the Code of Honor or such compliance policies. f. If Executive accepts employment with a third party during the Severance Period (as defined herein), Executive shall provide notice of the same to the Company, which notice shall include the name of Executive’s new employer, the title of the position accepted and a summary of the primary duties and responsibilities of such position. 2. Accrued Benefits. a. The Company shall continue to pay Executive his normal base salary earned through the Separation Date, or such earlier date that Executive’s employment with the Company ends, in accordance with its usual payroll practices. Executive will be eligible to receive payment under the Company’s 2021 Annual Incentive Plan or the 2021 Executive Incentive Plan in accordance with the terms thereof and payable at the time such payments are made under such plan (“2021 Bonus Payment”); provided, however, that Executive must be employed in good standing with the Company on the date such payment is due to be made to be eligible to receive such payment. The 2021 Bonus Payment shall be calculated based on the financial metrics approved by the Company’s Board of Directors and assuming Executive’s performance at 100% with respect to Executive’s personal management business objectives (“MBOs”). b. The Company shall reimburse Executive for any business expenses incurred by Executive prior to the Separation Date related to his employment with the Company, subject to the requirements of the Company’s expense reimbursement policy. All such reimbursement will be made in accordance with the Company’s expense reimbursement policy. c. Executive acknowledges and agrees that as of the Separation Date, except as otherwise set forth in this Agreement, the Company shall have no obligation to continue Executive’s coverage under the Company’s medical, dental, life insurance, or other employee insurance or benefit plans; provided, however, that Executive will be eligible for COBRA coverage to the extent required by applicable law. Executive understands and acknowledges that COBRA coverage will be at Executive’s sole expense and will be offered at 102% of the full cost of coverage. Executive will receive applicable COBRA election forms under separate cover following the Separation Date. d. Executive acknowledges and agrees that, subject to the Company’s compliance with the terms of this Agreement, the Company has paid or will have paid Executive in full all accrued salary, expenses, reimbursements, vacation, sick leave, and other payments to which Executive may have been

Page 3 of 15 entitled, and that there are no sums or other benefits, other than as described in this Agreement, due or owing to Executive by the Company. 3. Severance Benefits. a. In consideration of Executive’s promises, covenants and agreements set forth in this Agreement (including but not limited to the covenants regarding Confidentiality, Non‐Competition and Non‐Solicitation), and in accordance with Section 5 of the Policy, the Company shall provide Executive with the payments and benefits set forth in this Section 3 (collectively, the “Severance Benefits”). Executive acknowledges and Agrees that Executive would not be entitled to the Severance Benefits in the absence of Executive’s acceptance of this Agreement and adherence with its terms. Executive further acknowledges and agrees that Executive shall not be entitled to any Severance Benefits if the Company terminates Executive for Cause (as defined in the Policy) or the Executive abandons his employment prior to the Separation Date. Executive also acknowledges and agrees that if Executive violates any of the Protective Covenants (as defined herein), Executive shall repay to the Company any of the Severance Benefits that Executive has received as of the date of such violation and that the Company thereafter shall have no obligation to provide any Severance Benefits to Executive. b. Subject to the terms of this Agreement, the Company shall pay Executive a lump‐sum in the gross amount of ONE MILLION, FIVE HUNDRED NINETY‐NINE THOUSAND, SIX HUNDRED NINETY DOLLARS AND NO CENTS ($1,599,690.00), less all applicable withholdings and deductions. The Company shall make this payment on the first regularly scheduled Company payday following the latter of the Effective Date of this Agreement or the Subsequent Release Effective Date (as that term is defined in the Subsequent Release). For purposes of this Agreement, “Severance Period” shall mean the eighteen (18)‐ month period immediately following the Separation Date. c. Subject to the terms of this Agreement, the Company shall pay Executive a lump‐sum cash Welfare Benefit Payment (as defined in the Policy) equal to SEVENTEEN THOUSAND EIGHTY‐EIGHT DOLLARS AND NO CENTS ($17,088.00). The Company shall make this payment on the first regularly scheduled Company payday following the latter of the Effective Date of this Agreement or the Subsequent Release Effective Date. d. Executive currently holds 203,014 shares of restricted stock in the Company (the “Restricted Stock”) issued and outstanding under O&M’s 2018 Stock Incentive Plan (as amended) (the “2018 Stock Plan”). The Restricted Stock shall continue to vest under the 2018 Stock Plan in accordance with the terms thereof through and until the Separation Date, so long as Executive remains employed in good standing through such date. Executive will receive a pro‐rated amount of his unvested Restricted Stock based on his Separation Date as provided by the applicable plan documents and award agreements. Under the applicable plan and award agreements, the restrictions on 173,435 shares will lapse and the remaining shares of the Restricted Stock shall be forfeited, each upon the latter of the Effective Date of this Agreement or the Subsequent Release Effective Date. Performance share awards to Executive under the grant made on May 11, 2020 shall be governed by the applicable plan and performance share award agreement, and Executive shall receive a pro‐rated portion of any restricted stock issued pursuant to such award based on the Separation Date. Executive understands and agrees that all of Executive’s outstanding performance share awards under the grant made on March 1, 2021, shall be forfeited as of the Separation Date in accordance with the applicable performance share award agreement. Executive’s current restricted stock and performance share positions, and the treatment of each under this Agreement, are set forth in Exhibit B – Executive Stock Holdings, which is attached hereto and incorporated herein by this reference. Notwithstanding anything to the contrary herein, nothing in this Agreement shall be construed to waive or otherwise alter any of the provisions of the applicable plan or award agreements pertaining to restricted stock or performance shares awards issued

Page 4 of 15 to Executive during his employment with the Company. All provisions of such plans and award agreements shall survive and remain in full force and effect. e. Subject to the terms of this Agreement, the Company shall pay Executive a lump‐sum cash payment equal to TEN THOUSAND DOLLARS ($10,000.00), less required deductions, for outplacement services. The Company shall make this payment on the first regularly scheduled Company payday following the latter of the Effective Date of this Agreement or the Subsequent Release Effective Date. f. Subject to the terms of this Agreement, the Company shall pay Executive a lump‐sum cash payment equal to FIVE THOUSAND TWO HUNDRED FIFTY DOLLARS ($5,250.00), less required deductions, for tax preparation services. The Company shall make this payment on the first regularly scheduled Company payday following the latter of the Effective Date of this Agreement or the Subsequent Release Effective Date. g. Any amount described in this Section 3, to the extent earned, shall be paid to Executive in no event later than the fifteenth (15th) day of the third (3rd) month following the end of the year in which such amount was no longer subject to a substantial risk of forfeiture, within the meaning of Code Section 409A of the Internal Revenue Code of 1986, as amended (the “Code”), except as may be permitted pursuant to Treasury Regulation Section 1.409A‐1(b)(4)(ii). h. Executive acknowledges and agrees that Executive’s agreement to abide by and compliance with the Protective Covenants (as defined herein) is a material inducement for the Company to enter into this Agreement and is consideration for the Severance Benefits and other benefits afforded to Executive hereunder. Accordingly, Executive agrees that if Executive breaches any provision of any Protective Covenant, the Company shall have no obligation to provide any of the Severance Benefits set forth in this Section 3 and Executive shall be obligated to repay to the Company any amounts already received by Executive as of the date of such breach. 4. Covenant to Maintain Confidentiality. During his employment with the Company, Executive has been exposed to certain Confidential Information of the Company. For purposes of this Agreement “Confidential Information” means information, in any form, related to the Company’s business (i) that is not generally known or available to individuals or entities outside of the Company, (ii) in which the Company has an interest, (iii) from which the Company derives value by virtue of – in whole or in part – its confidentiality, and (iv) with respect to which the Company takes reasonable measures to maintain as confidential. Such Confidential Information includes but is not limited to: information technology and computer systems; trade secrets; financial or investor relations information; sales activity information; accounting information; revenue recognition information; cash‐flow information; lists of and other information about current and prospective customers, vendors or suppliers; prices or pricing strategy or information; sales and account records; reports, pricing, sales manuals and training manuals regarding selling, strategic planning and business development information; purchasing, and pricing procedures and financing methods of the Company, together with any specific and proprietary techniques utilized by the Company in designing, developing, testing or marketing its products, product mix and supplier information or in performing services for clients, customers and accounts of the Company; information concerning existing or contemplated software, products, services, technology, designs, processes and research or product developments of the Company; and, any other information of a similar nature made available to Executive and not known to the public, which, if misused or disclosed, could adversely affect the business or interests of the Company. Confidential Information includes any such information that Executive may have prepared or created during his employment with the Company, as well as such information that has been or may be created or prepared by others. Confidential Information shall not include any information that has been voluntarily disclosed to the public by the Company, has been

Page 5 of 15 independently developed and disclosed to the public by others without violating any legal obligation, or otherwise enters the public domain through lawful means. Subject to the limited exclusions and limitations set forth in this Agreement, Executive agrees that for as long as such information remains confidential to the Company, including after the Severance Period, or is a trade secret under applicable law, Executive will not disclose any Confidential Information to any person, agency, institution, company, or other entity, and Executive will not use any Confidential Information in any way, except as required by Executive’s duties to the Company or by law, or as permitted under Section 9 of this Agreement. In the event that Executive is unsure whether or not certain information is Confidential Information, Executive will send the Company a written inquiry about whether such information is covered under this Agreement. Notwithstanding anything to the contrary contained herein, this Agreement does not prohibit Executive from complying with a lawful subpoena or other legal compulsion. If Executive becomes legally compelled (by interrogatories, requests for information or documents, subpoenas, civil investigative demands, applicable regulations, or similar processes) to disclose any Confidential Information, Executive shall, if permitted by applicable law, provide Company with prompt notice so that Company may seek an appropriate protective order or other appropriate remedy or waive Executive’s compliance with this Section 4, which waiver must be in writing to be effective. If that protective order or other remedy is not obtained by the date that Executive must comply with the request, or if Company waives compliance with this Section 4 in writing, Executive shall furnish only that portion of the Confidential Information that is legally required to be provided in the reasonable opinion of Executive’s counsel (after consultation with Company’s counsel), and Executive shall exercise commercially reasonable efforts to obtain a protective order or other reliable assurance that confidential treatment will be accorded to that portion of the Confidential Information of Company which is being furnished or disclosed. 5. Covenant not to Compete. Executive acknowledges and agrees that Executive, as President of the Company’s Global Products business unit, was responsible for all of the business activity conducted by the Global Products business unit, and that the Company’s Global Products business unit conducted business and sold products in markets throughout the world. During the Transition Period and Severance Period, Executive agrees not to engage in Competitive Work for or on behalf of a Competitor engaged in a Competitive Business in any country in which the Company’s Global Products business unit sold products at any time within the Recent Period (as defined herein). Notwithstanding the foregoing, this Section 5 does not restrict Executive from owning stock or other securities of a publicly held corporation in which Executive does not possess beneficial ownership of more than 2% of such corporation’s voting stock. For purposes of this Agreement, “Competitive Business” means providing or soliciting to provide or sell surgical and/or infection prevention products that are substantially similar to or competitive with the products provided, offered or planned to be offered by the Company’s Global Products business unit at any time during the last twelve (12) months of Executive’s employment with the Company (the “Recent Period”). “Competitive Work” means the performance of duties and/or provision of services (whether as an employee, independent contractor or otherwise) that are substantially similar to duties and/or services that Executive performed or provided for or on behalf of O&M at any time during the Recent Period. “Competitor” means any person or entity that is engaged in conducting Competitive Business. 6. Non‐Solicitation of Customers & Suppliers. During the Transition Period and Severance Period, Executive agrees that he will not, personally or through another: conduct or offer to conduct any Competitive Business with any Covered Customer; or encourage or induce any Covered Customer or Covered Supplier to cease doing business with the Company or change the terms of an existing business relationship with the Company to the detriment of the Company. Notwithstanding the foregoing, this Section 6 does not prohibit general advertising or solicitation that is not specifically directed to a

Page 6 of 15 Covered Customer(s) or Covered Supplier(s). For purposes of this Agreement, “Covered Customer” means any individual or entity with which O&M, at any time during the Recent Period, has conducted, or made a written or in‐person proposal to conduct, business or to which the Company has provided or offered to provide goods or services, and with whom or which Executive had business‐related contact or dealings on behalf of O&M or about which Executive received Confidential Information, in each case, at any time during the Recent Period. “Covered Supplier” means any manufacturer or supplier of medical or surgical products or devices or raw materials used by the Company to manufacture products sold by the Company with which O&M, at any time during the Recent Period, has conducted or made a written or in‐person proposal to conduct, business, and with which Executive had business‐related contact or dealings on behalf of O&M or about which Executive received Confidential Information, in each case, at any time during the Recent Period. 7. Non‐Solicitation of Workers. During the Transition Period and Severance Period, Executive agrees that he will not, personally or through another, solicit for employment or hire a Covered Worker for employment or engagement by any person or entity other than O&M or encourage a Covered Worker to leave employment with the Company. Notwithstanding the foregoing, the restrictions contained in this Section 7 shall not apply to any individual that has been separated from employment with the Company for six (6) months or more as of the time of recruitment, solicitation or hiring by Executive. This Section 7 also does not prohibit general advertising or solicitation not specifically directed to a Covered Worker or Covered Workers. For purposes of this Agreement, “Covered Worker” means any person who at any time during the Recent Period (i) was employed or engaged by the Company; and (ii) had business‐related contact with or reported to Executive. 8. Non‐Disparagement. Executive agrees that he shall not make any statement or take any action that reasonably could be construed as criticizing or disparaging the reputation of any Releasee (as defined below). This provision is in addition to, and not in lieu of, the substantive protections under applicable law relating to defamation, libel, slander, interference with contractual or business relationships, or other statutory, contractual or tort theories. Notwithstanding the foregoing, Executive understands and agrees that Executive’s obligations under this Section 8 are expressly limited by the provisions of Section 9 of this Agreement. Further, nothing herein shall be construed to require Executive or any other person to engage in any unlawful act. 9. Limitations on Obligations. Nothing in this Agreement shall prohibit or impede Executive from communicating, cooperating or filing a complaint with any U.S. federal, state or local governmental or law enforcement branch, agency or entity (each, a “Governmental Entity”) with respect to possible violations of any U.S. federal, state or local law or regulation, or otherwise making disclosures to any Governmental Entity, in each case, that are protected under the whistleblower provisions of any such law or regulation, provided that in each case such communications and disclosures are consistent with applicable law. Executive does not need the prior authorization of (or to give notice to) the Company regarding any such communication or disclosure. This Agreement also does not limit Executive’s right to receive an award for information provided to any federal, state or local government agency or self‐ regulatory organization, or to engage in any future activities protected under whistleblower statutes. Additionally, Executive hereby confirms that she or he understands and acknowledges that an individual shall not be held criminally or civilly liable under any federal or state trade secret law for the disclosure of a trade secret that is made in confidence to a federal, state, or local government official or to an attorney solely for the purpose of reporting or investigating a suspected violation of law, or in a complaint or other document filed in a lawsuit or other proceeding, if such filing is made under seal. Executive understands and acknowledges further that an individual who files a lawsuit for retaliation by an employer for reporting a suspected violation of law may disclose the trade secret to the

Page 7 of 15 attorney of the individual and use the trade secret information in the court proceeding, if the individual files any document containing the trade secret under seal; and does not disclose the trade secret, except pursuant to court order. Notwithstanding the foregoing, under no circumstance will Executive be authorized to disclose any information covered by the Company’s attorney‐client privilege or the Company’s attorney work product without prior written consent of the Company’s General Counsel or other officer designated by the Company, or unless such disclosure of that information would otherwise be permitted pursuant to 17 CFR 205.3(d)(2), applicable state attorney conduct rules, or otherwise under applicable law or court order. 10. Reasonableness & Remedies. a. The covenants contained in Sections 4, 5, 6, 7 & 8 of this Agreement (the “Protective Covenants”) are, in light of the nature of Executive’s employment by the Company, reasonable and necessary for the protection of the Company’s legitimate business interests, specifically including the Company’s interest in the Confidential Information and the Company’s significant investment to develop and maintain its business relationships and goodwill. b. In the event that Executive breaches any provision(s) of the Protective Covenants, Executive Acknowledges and agrees that the duration of the Protective Covenant that Executive has breached shall be extended by the length of time that Executive was in breach of such provision(s). c. Executive acknowledges and agrees that the Company will suffer irreparable harm if Executive breaches any provision of the Protective Covenants, and the Company shall be entitled to, in addition to any other available remedies, temporary and/or permanent injunctive relief against Executive barring any conduct in violation of any provision of the Protective Covenants. No claim or cause of action Executive may have or assert against the Company, whether predicated on this Agreement or otherwise, shall serve as or constitute a defense to the enforcement of any provision of the Protective Covenants. Should the Company prevail in any claim, dispute or action arising from or relating to this Agreement (a “Covered Claim”), whether initiated by the Company or Executive, the Company shall be entitled to recover from Executive all costs, including attorneys’ fees, incurred by the Company in connection with such Covered Claim. 11. General Release. a. For purposes of this Agreement, “Releasee” and “Releasees” means the Company and any and all O&M boards, past and present directors, trustees, officers, shareholders, members, partners, managers, supervisors, employees, attorneys, agents, representatives, insurers and consultants, as well as the predecessors, successors and assigns of any of them, and all persons or entities acting by, with, through, under or in contract with any of them. Except as specifically provided below, for purposes of this Agreement the term “Claims” means: each and every claim, complaint, cause of action, grievance, demand, controversy, allegation, or accusation, whether known or unknown; each and every promise, assurance, contract, representation, obligation, guarantee, warranty, liability, right, agreement and commitment of any kind, whether known or unknown; and all forms of relief, including, but not limited to, all remedies, costs, expenses, losses, damages, debts and attorneys’ and other professionals’ fees and related disbursements, whether known or unknown. Notwithstanding the foregoing, Claims do not include a charge of discrimination with the Equal Employment Opportunity Commission (“EEOC”). Thus, this Agreement does not preclude Executive from filing an EEOC charge or participating in an EEOC investigation. b. Subject to the limited exclusions and limitations set forth below and in Section 9 of this Agreement, Executive hereby irrevocably releases and forever discharges all Releasees from any and all Claims that Executive, or anyone on his behalf ever had or now has against any and all of the Releasees,

Page 8 of 15 or which Executive, or any of his executors, administrators, representatives, attorneys or assigns, hereafter can, shall or may have against any and all of the Releasees for or by reason of any cause, matter, thing, occurrence, or event whatsoever from the date of Executive’s birth to the date that Executive signs this Agreement. Executive acknowledges and agrees that the Claims released in this paragraph include, but are not limited to, (a) any and all Claims based on any law, statute, or constitution or based on contract or in tort or in common law, and any and all Claims based on or arising under any civil rights laws, such as the civil rights laws of any state or jurisdiction, Title VII of the Civil Rights Act of 1964, the Age Discrimination in Employment Act (“ADEA”), the Equal Pay Act, the Americans with Disabilities Act of 1990, the Civil Rights Act of 1991, the Family Medical Leave Act, or the Virginia Human Rights Act; (b) any and all Claims under any grievance or complaint procedure of any kind; and (c) any and all Claims based on or arising out of or related to Executive’s recruitment by, employment with, the termination of Executive employment with, of my performance of any service in any capacity for, or any business transaction with, each or any of the Releasees (collectively, the “Released Claims”). Executive also hereby waives any and all right to personal recovery of money damages or other relief for any of the Claims released by this Section 11. Executive hereby represent and warrant that I have not assigned any claim to any third party. c. Notwithstanding the foregoing, Executive does not waive, and Released Claims shall not include: (i) any rights, Claims or protections that Executive may have under this Agreement; (ii) any rights, Claims, and protections based on any cause, matter, thing, or event arising or occurring at any time after Executive signs this Agreement; (iii) Executive’s rights, Claims, and protections, if any, to vested or guaranteed benefits under the Company’s qualified and non‐qualified benefit plans; (iv) any rights, Claims, or protections Executive may have under the applicable terms of such policy or plan to convert his existing coverage under any group life, disability, and/or accidental death and dismemberment plan offered by the Company; (v) any rights, Claims, or protections Executive may have to continuation of group health, dental, or vision insurance as provided by the Consolidated Omnibus Budget Reconciliation Act of 1985 (“COBRA”), as amended by the Health Insurance Portability and Accountability Act of 1996 and the American Recovery and Reinvestment Act of 2009; (vi) any rights, Claims, or protections Executive has, had, or may have under Article V of the Amended and Restated Articles of Incorporation of Owens & Minor, Inc. (“Articles of Incorporation”), including the indemnification and advancement provisions contained therein, as of the Effective Date of this Agreement; (vii) any rights, Claims, or protections Executive has, had, or may have under any policy or contract of indemnification, liability or other type of insurance, or other undertaking from and/or against any Claims asserted, liability incurred, or proceeding initiated or maintained against Executive arising from, related or pertaining to, or serving as its basis or their bases, Executive’s capacity as an officer of the Company or his alleged acts, omissions, or inaction in such capacity, the foregoing being without regard to whether the Company has, had, or may have the power or obligation to indemnify Executive or provide advancements against such liability under Article V of the Articles of Incorporation; (viii) rights, Claims, or protections that Executive may have arising under the Age Discrimination in Employment Act of 1967 (“ADEA”), or the Older Workers Benefit Protection Act of 1990, which amends the ADEA, after Executive signs this Agreement; or (ix) any rights, Claims or protections that Executive, by law, is prohibited from releasing under this Agreement. d. Notwithstanding any provision of this Agreement to the contrary, O&M reaffirms and restates its obligations to Executive under Article V of its Articles of Incorporation, amended and current as of the Separation Date, including the indemnification and advancement provisions contained therein. In no way limiting the foregoing, and as an inducement to Executive’s acceptance and execution of this Agreement, O&M acknowledges and agrees that as of the date that it executes this Agreement (i) the Company’s officers and directors are not aware of any actions, omissions, or inaction

Page 9 of 15 by Executive that would negate Executive’s rights to indemnification and advancements under the Articles of Incorporation of O&M; and (ii) the Company’s officers and directors are not aware of any actions, omissions, or inaction by Executive that could give rise to any Claims by O&M or its Related Entities against Executive. 12. No Admission. The offer of this Agreement and the Agreement itself are not an admission, and shall not be construed to be an admission, by each or any of the Releasees, that the personnel, employment, termination and any other decisions involving Executive or any conduct or actions at any time affecting or involving Executive were wrongful, discriminatory, or in any way unlawful or in violation of any right of Executive; moreover, any such liability or wrongdoing is denied by Executive. Executive shall not attempt to offer this Agreement or any of its terms as evidence of any liability or wrongdoing by each or any of the Releasees in any judicial, administrative or other proceeding now pending or hereafter instituted by any person or entity. 13. Period for Review & Revocation. Executive acknowledges that he has been afforded twenty‐one (21) days after receiving this Agreement, including the Subsequent Release, to consider whether or not to enter into it. Executive may use as much or as little of this 21‐day period as Employee wishes to decide whether or not to sign this Agreement. Executive may revoke this Agreement within seven (7) days of signing it by delivering a written notice of revocation to the Company’s General Counsel at 9120 Lockwood Boulevard, Mechanicsville, Virginia 23116. For a revocation to be effective, written notice must be received no later than the close of business on the seventh (7th) day after Executive signs this Agreement. If Executive revokes this Agreement, it shall not be effective or enforceable, and the Company shall not be obligated to provide Employee any benefits hereunder. If Executive has not revoked the Agreement, the eighth (8th) day after Executive signs this Agreement shall be the “Effective Date” for purposes of this Agreement. 14. Encouragement to Consult with an Attorney. The Company has advised Executive to consult an attorney about this Agreement before signing it. By signing this Agreement, Executive represents that he has consulted with an attorney about this Agreement or has voluntarily chosen not to do so. Executive also acknowledges and agrees that the Company is not obligated to pay any of his attorneys’ fees, costs or expenses relating to this Agreement and that the release in Section 11, above, releases, among other things, all Claims for attorneys’ fees, costs and expenses. Executive acknowledges that he is signing this Agreement voluntarily, with full knowledge of the nature and consequences of its terms and without duress or undue influence by the Company or any other person or entity. 15. No Release of Future Claims. This Agreement does not waive or release any rights or claims that Employee may have under the ADEA or otherwise which arise after the date that Employee signs this Agreement. The parties acknowledge and agree that the decision to end Employee’s employment with the Company was made prior to Employee signing this Agreement. 16. Taxes. The Company will withhold from any amounts due Executive under this Agreement payroll deductions as required by law and determined by the Company. Executive understands and acknowledges that he is responsible for all taxes that he may incur with respect to any of the consideration to be delivered to him under this Agreement. Notwithstanding any other provision of this Agreement, it is intended that any payment or benefit provided hereto that is considered nonqualified deferred compensation subject to Section 409A of the Internal Revenue Code of 1986, as amended (the “Code”), will be provided and paid in a manner, and at such time and in such form, as complies with the applicable requirements of Section 409A of the Code. For purposes of this Agreement, all rights to payments and benefits hereunder will be treated as rights to a series of separate payments and benefits to the fullest extent allowable by Section 409A of the Code. Notwithstanding any other provision of this

Page 10 of 15 Agreement, however, none of the Releasees shall be liable to Executive in the event any provision of this Agreement fails to comply with, or be exempt from, Section 409A of the Code. 17. Governing Law. The Company is a global business headquartered in the Richmond metropolitan area of Virginia, and this contract was made in whole or in part in Virginia. This Agreement shall be construed and enforced under the laws of the Commonwealth of Virginia, without regard to its conflicts of law principles. 18. Forum Jurisdiction & Venue. The exclusive forums and venues for any Covered Claim, shall be the federal courts located in Richmond, Virginia, and the state courts located Henrico county, Virginia (each a “Chosen Forum” and, collectively, the “Chosen Forums”); provided, however, that the Company may, in its sole discretion, choose to bring a Covered Claim in any other court that otherwise would have jurisdiction over such Covered Claim. Executive expressly and irrevocably consents and submits to the personal jurisdiction of each Chosen Forum over Executive for any Covered Claim and expressly agrees that venue for any Covered Claim is appropriate therein. Executive shall not file any Covered Claim in any forum other than a Chosen Forum and waives any and all objections to the jurisdiction of or venue in a Chosen Forum for a Covered Claim. A final judgment in any action or proceeding in a Chosen Forum shall be conclusive and may be enforced in other jurisdictions in accordance with applicable law; provided, however, that this Section 18 does not affect either party’s right to appeal a judgment. Executive acknowledges that Executive has read this Section 18, understands it and has voluntarily agreed to its terms. 19. WAIVER OF JURY TRIAL. EXECUTIVE KNOWINGLY AND WILLFULLY WAIVES ANY RIGHT HE MAY HAVE UNDER APPLICABLE LAW TO A TRIAL BY JURY IN ANY DISPUTE OR ISSUE ARISING OUT OF OR IN ANY WAY RELATED TO A COVERED CLAIM. 20. Severability & Reformation. a. The provisions of this Agreement, including the Protective Covenants, are expressly intended to be severable and separately enforceable. If any clause or provision of this Agreement is ruled invalid or limited by any regulatory agency or court of competent jurisdiction, the invalidity of such clause or provision shall not affect the validity of the other provisions, which provisions shall be enforced to the fullest extent permitted by law. b. In the event that a court of competent jurisdiction determines that any provision of the Protective Covenants is invalid or unenforceable under applicable law by reason of its geographic, temporal or other scope, or the extent of restriction imposed on Executive’s activity, the court making such determination shall reduce the applicable scope and/or the extent of restriction by such amount as is minimally necessary to render such provision, as so amended, valid and enforceable under applicable law. Notwithstanding the foregoing, should it be determined that the provisions of this Section 20.b are impermissible under applicable law then this subsection shall be deemed null and void, and such determination shall not affect the validity of the remainder of this Agreement. 21. Notices. All notices permitted or required under this Agreement shall be given in writing and addressed or delivered to the persons specified in this Agreement. Any notice or communication required hereunder shall be given by hand; FedEx or UPS next‐business‐day delivery service; registered, certified, or express United States mail (postage prepaid). The date of receipt of any notice shall be the date the notice is deemed to have been given. Notices permitted or required hereunder shall be given to the following individuals: To the Company: Owens & Minor, Inc.

Page 11 of 15 Attn: General Counsel 9120 Lockwood Boulevard Mechanicsville, Virginia 23116 To Executive: Christopher Lowery _______________________________ _______________________________ 22. Entire Agreement & Modification. This Agreement contains the entire understanding and agreement of the parties regarding the subject matter hereof. The terms of this Agreement are contractual and, except as provided under Section 20.b hereof, shall not be deemed to have been altered, modified or in any way changed by any statements, promises, discussions or agreements not appearing herein. Except as provided under Section 20.b hereof, this Agreement may not be modified, amended or altered except by a writing signed by both the parties. 23. Assignment. This Agreement shall be binding upon and inure to the benefit of the Company and any corporation or other entity to which the Company may transfer all or substantially all of its assets or to which the Company may assign this Agreement. Executive hereby consents to any such assignment without further notice to or consent from Executive. Executive may not assign this Agreement or any part hereof without the prior written consent of O&M’s General Counsel. 24. Return of Company Property. Following the Separation Date, Executive will immediately return to the Company any Company property and all such records without deleting, destroying, or otherwise damaging the utility of same. 25. Miscellaneous. This Agreement may be executed in one or more counterparts each of which will constitute one and the same instrument, and all executed copies of this Agreement and facsimiles thereof shall be as legally binding and enforceable as the original. Executive’s obligations under this Agreement shall survive the termination of Executive’s employment with the Company regardless of the reason and any breach by the Company of this Agreement or any other obligation of the Company. The waiver by any party of a breach of any condition or provision of this Agreement to be performed by the other party shall not operate or be construed as a waiver of a similar or dissimilar provision or condition at the same or any prior or subsequent time. The Executive represents and warrants that he owns all Claims released by this Agreement and he has not sold or assigned any such claim to any other party, by operation of law or otherwise, including to any bankruptcy trustee. The captions and headings in this Agreement are included for convenience only and shall not be construed to define or limit any of the provisions contained herein. REMAINDER OF PAGE INTENTIONALLY BLANK SIGNATURE PAGE FOLLOWS

Page 12 of 15 IN WITNESS WHEREOF, and intending to be legally bound, each of the parties has caused this Confidential Executive Separation Agreement & General Release to be executed either individually or in its entity name by its duly authorized representative. BY SIGNING BELOW, EXECUTIVE EXPRESSLY ACKNOWLEDGES THAT EXECUTIVE IS SIGNING THIS AGREEMENT VOLUNTARILY AND OF HIS/HER OWN FREE WILL, WITH FULL KNOWLEDGE OF THE NATURE AND CONSEQUENCES OF ITS TERMS. EMPLOYEE HAS READ THIS AGREEMENT CAREFULLY AND UNDERSTANDS THAT IT CONTAINS A RELEASE OF ALL KNOWN AND UNKNOWN CLAIMS. CHRISTOPHER LOWERY OWENS & MINOR, INC. Date: ___/___/______ Name:__________________________________ Title: Date: ___/___/______

Page 13 of 15 EXHIBIT A RELEASE OF CLAIMS 1. On January ____, 2022, I entered into that certain Confidential Executive Separation Agreement and General Release (the “Separation Agreement”) with Owens & Minor, Inc. (the “Company”). My employment with the Company ended on the Separation Date (as defined in the Separation Agreement). I confirm that, except for the Severance Benefits (as defined in the Separation Agreement), reimbursable expenses due pursuant to Section 2.b of the Separation Agreement and the benefits set forth in Section 3 of the Separation Agreement, I have been paid all compensation owed for all hours worked by me for the Company through the Separation Date. I have received all the leave and leave benefits and protections for which I was eligible in connection with my employment with the Company, pursuant to the Family and Medical Leave Act or otherwise, and I have not suffered any on‐ the‐job injury for which I have not already filed a claim. 2. General Release. In consideration of the Severance Benefits paid or payable pursuant to Section 3 of the Separation Agreement, I hereby waive and release the Company, its parents, subsidiaries, predecessors, successors and affiliates, and each of such entities’ officers, directors, employees, shareholders, managers, members, agents, representatives and assigns (collectively, the “Released Parties”) from any and all claims, liabilities, demands, causes of action, attorneys’ fees, damages, or obligations of every kind and nature, whether known or unknown, arising at any time prior to and including the date I sign this Release of Claims (the “Release”). This general release includes, but is not limited to: (a) all claims directly or indirectly arising out of or in any way connected with my employment with the Company or the termination of that employment relationship; (b) all claims or demands related to salary, bonuses, fees, retirement contributions, profit‐sharing rights, profit distributions, management fee income, commissions, carried interest, membership interests, unit options, or any other ownership or equity interests in the Company or any of its affiliated entities, vacation pay, fringe benefits, expense reimbursements or any other form of compensation or benefit, except claims for benefits or compensation due to me under the Separation Agreement or the Consulting Agreement; (c) all claims pursuant to any federal, state or local law, statute or cause of action in any jurisdiction, including, but not limited to, the federal Civil Rights Act of 1964 (as amended), the federal Americans with Disabilities Act of 1990, the federal Age Discrimination in Employment Act of 1967 (as amended) (the “ADEA”, the Family Medical Leave Act, the Equal Pay Act, anti‐discrimination statutes, tort law, contract law, wrongful discharge, discrimination, harassment, fraud, defamation, emotional distress, or claims for breach of fiduciary duty. Notwithstanding the foregoing, nothing in this paragraph shall release any of the rights, claims and protections set forth in Section 11(c) of the Separation Agreement. 3. ADEA Waiver and Release. I am over 40 years of age as of the Separation Date and I acknowledge that I am knowingly and voluntarily waiving and releasing any rights I may have under the ADEA. I acknowledge that the consideration given for this waiver and release is in addition to anything of value to which I was already entitled. I further acknowledge that I have been advised by this writing, as required by the ADEA, that: (a) this Release does not apply to any rights or claims that arise after the date I sign it; (b) I should consult with an attorney before signing this Release; (c) I have been provided at least twenty‐one (21) days to consider this Release; (d) I have seven (7) days after the date I sign this Release to revoke my acceptance of it (by sending written notice of such revocation to the Company); and (e) this Release will not be effective until the date upon which this revocation period has expired unexercised, which, assuming I do not earlier revoke my acceptance of it, will be the eighth (8th) day after I sign this Release (the “Subsequent Release Effective Date”).

Page 14 of 15 4. Limitations on Obligations. I understand and agree that this Release is to be broadly construed, provided that notwithstanding anything contained herein, this Release expressly does not include a release of any claims that cannot be released by law or under applicable public policy. Additionally, I understand and agree that nothing in this Release is intended to, or shall, interfere with my rights under federal, state, or local laws (including, but not limited to, the statutes referenced herein, or their state or local counterparts) to file or otherwise institute a charge of discrimination, to participate in a proceeding or investigation with any appropriate federal, state, or local government agency, or to cooperate with any such agency in its investigation, none of which shall constitute a breach of this Release. I also acknowledge and agree, however, that I shall not be entitled to any relief, recovery, or monies in connection with any such claim or proceeding brought against any of the Released Parties, regardless of who filed or initiated any such complaint, charge or proceeding. Nothing contained in this Release is designed to prohibit me from disclosing this Release to the EEOC or any other government agency. I understand that I am free to do so if I choose. I also understand that this Release may not affect the rights and responsibilities of the EEOC to enforce federal laws or be used to justify interfering with the protected right of Employee or others to file a charge with the EEOC. Additionally, nothing in this Release shall prohibit me or others from participating in any investigation or proceeding conducted by the EEOC, the National Labor Relations Board, the Securities and Exchange Commission or other state or federal agency. 4. Entire Agreement. This Release, together with the Separation Agreement (including any exhibits thereto), constitutes the complete, final and exclusive embodiment of the entire agreement between me and the Company with regard to their subject matter, and I am not relying on any promise, warranty or representation that is not expressly stated therein. Understood, Accepted and Agreed: Signature: Printed Name: Date:

Page 15 of 15 EXHIBIT B EXECUTIVE STOCK HOLDINGS


Virginia			54-1701843
(State or other jurisdiction of incorporation or organization)			(I.R.S. Employer Identification No.)

9120 Lockwood Boulevard	Mechanicsville	Virginia	23116
(Address of principal executive offices)			(Zip Code)

Post Office Box 27626, Richmond, Virginia			23261-7626
(Mailing address of principal executive offices)			(Zip Code)



Item No.		Page
Part I

1	Business	3
1A.	Risk Factors	10
1B.	Unresolved Staff Comments	20
2	Properties	20
3	Legal Proceedings	21

Part II
4	Mine Safety Disclosures	21
5	Market for Registrant’s Common Equity, Related Stockholder Matters , and Issuer Purchases of Equity Securities	21
6	Reserved	22
7	Management’s Discussion and Analysis of Financial Condition and Results of Operations	23
7A.	Quantitative and Qualitative Disclosures About Market Risk	32
8	Financial Statements and Supplementary Data	32
9	Changes in and Disagreements with Accountants on Accounting and Financial Disclosure	32
9A.	Controls and Procedures	33
	Management’s Report on Internal Control over Financial Reporting	33
9B.	Other Information	33
	Report of Independent Registered Public Accounting Firm	34

Part III

10	Directors and Executive Officers of the Registrant	35
11	Executive Compensation	35
12	Security Ownership of Certain Beneficial Owners and Management	35
13	Certain Relationships and Related Transactions	35
14	Principal Accountant Fees and Services	35

Part IV

15	Exhibits and Financial Statement Schedules	36


	Owned	Leased	Other	Total	Location
Production	6	12	—	18	United States, Europe, Honduras, Mexico and Thailand
Distribution	1	46	1	48	United States and India
Storage	—	14	—	14	United States, Honduras and Mexico
Office	1	30	—	31	United States, Asia, Australia, Canada and Europe
Total	8	102	1	111


	Base Period		Years Ended
Company Name / Index	12/2016		12/2017		12/2018		12/2019		12/2020		12/2021
Owens & Minor, Inc.	$	100.00	$	55.55	$	19.72	$	16.14	$	84.54	$	135.99
S&P 500 Index	100.00		119.42		111.97		114.31		167.77		212.89
S&P 500 Healthcare	100.00		120.00		125.63		149.10		166.14		206.29


	At or for the years ended December 31,
	2021			2020			2019
Summary of Operations:
Net revenue	$	9,785,315		$	8,480,177		$	9,210,939

Income (loss) from continuing operations	$	221,589		$	88,074		$	(22,584)

Per Common Share:
Income (loss) from continuing operations per share—basic	$	3.05		$	1.39		$	(0.37)
Income (loss) from continuing operations per share—diluted	$	2.94		$	1.39		$	(0.37)
Cash dividends	$	0.01		$	0.01		$	0.01
Stock price at year end	$	43.50		$	27.05		$	5.17

Summary of Financial Position:
Total assets	$	3,536,551		$	3,335,639		$	3,643,084
Cash and cash equivalents	$	55,712		$	83,058		$	67,030
Total debt	$	949,577		$	1,025,967		$	1,559,652
Total equity	$	938,501		$	712,054		$	462,154

Selected Ratios:
Gross margin as a percent of revenue	15.46		%	15.10		%	12.25		%
Distribution, selling and administrative expenses as a percent of revenue	11.41		%	12.28		%	11.11		%
Operating income as a percent of revenue	3.77		%	2.41		%	0.79		%
Days sales outstanding (DSO) (1)	24.6			26.0			27.1
Inventory days (2)	64.7			57.8			55.3


☒			Annual Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934


☐			Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934


Net revenue.	For the years ended December 31,				Change
(Dollars in thousands)	2021		2020		$		%
Global Solutions	$	7,860,475	$	7,212,011	$	648,464	9.0	%
Global Products	2,655,728		1,810,331		845,397		46.7	%
Inter-segment	(730,888)		(542,165)		(188,723)		(34.8)	%
Net revenue	$	9,785,315	$	8,480,177	$	1,305,138	15.4	%


Cost of goods sold.	For the years ended December 31,				Change
(Dollars in thousands)	2021		2020		$		%
Cost of goods sold	$	8,272,086	$	7,199,343	$	1,072,743	14.9	%


Gross margin.	For the years ended December 31,						Change
(Dollars in thousands)	2021			2020			$		%
Gross margin	$	1,513,229		$	1,280,834		$	232,395	18.1	%
As a % of net revenue	15.46		%	15.10		%


Operating expenses.	For the years ended December 31,						Change
(Dollars in thousands)	2021			2020			$		%
Distribution, selling & administrative expenses	$	1,116,871		$	1,041,336		$	75,535	7.3	%
As a % of net revenue	11.41		%	12.28		%
Acquisition-related and exit and realignment charges	$	34,076		$	37,752		$	(3,676)	(9.7)	%
Other operating (income) expense, net	$	(6,191)		$	(2,372)		$	(3,819)	(161.0)	%


Interest expense, net.	For the years ended December 31,						Change
(Dollars in thousands)	2021			2020			$		%
Interest expense, net	$	48,090		$	83,398		$	(35,308)	(42.3)	%
Effective interest rate	4.61		%	6.39		%


Loss on extinguishment of debt	For the years ended December 31,				Change
(Dollars in thousands)	2021		2020		$		%
Loss on extinguishment of debt	$	40,433	$	11,219	$	29,214	260.4	%


Income taxes.	For the years ended December 31,						Change
(Dollars in thousands)	2021			2020			$		%
Income tax provision	$	55,165		$	21,834		$	33,331	152.7	%
Effective tax rate	19.9		%	19.9		%


	December 31,				Change
(Dollars in thousands)	2021		2020		$		%
Cash and cash equivalents	$	55,712	$	83,058	$	(27,346)	(32.9)	%
Accounts receivable, net	$	681,564	$	700,792	$	(19,228)	(2.7)	%
Days sales outstanding (1)	24.6		26.0
Merchandise inventories	$	1,495,972	$	1,233,751	$	262,221	21.3	%
Inventory days (2)	64.7		57.8
Accounts payable	$	1,001,959	$	1,000,186	$	1,773	0.2	%


Year ended December 31,	2021		2020		2019
Net income (loss)	$	221,589	$	29,871	$	(62,371)
Other comprehensive income (loss), net of tax:
Currency translation adjustments	(25,976)		25,283		7,250
Change in unrecognized net periodic pension costs	3,850		(3,756)		(6,545)
Change in gains and losses on derivative instruments	20,044		(7,329)		(7,800)
Total other comprehensive income (loss), net of tax	(2,082)		14,198		(7,095)
Comprehensive income (loss)	$	219,507	$	44,069	$	(69,466)


Year ended December 31,	2021		2020		2019
Operating activities:
Net income (loss)	$	221,589	$	29,871	$	(62,371)
Adjustments to reconcile net income (loss) to cash provided by operating activities:
Depreciation and amortization	90,621		93,336		116,678
Share-based compensation expense	25,016		20,010		15,803
Impairment charges	—		8,724		32,112
Loss on divestiture	—		65,472		—
Loss on extinguishment and modification of debt	40,433		11,219		830
Deferred income tax (benefit) expense	(29,736)		15,564		(17,402)
Provision for losses on accounts receivable	21,158		11,292		12,914
Changes in operating lease right-of-use assets and lease liabilities	1,463		(1,676)		(2,599)
Changes in operating assets and liabilities:
Accounts receivable	(2,201)		(34,818)		63,526
Merchandise inventories	(263,439)		(85,154)		127,921
Accounts payable	3,548		193,240		(235,631)
Net change in other assets and liabilities	692		5,278		104,801
Other, net	15,033		6,865		9,503
Cash provided by operating activities	124,177		339,223		166,085
Investing activities:
Proceeds from divestiture	—		133,000		—
Additions to property and equipment	(40,985)		(50,424)		(42,419)
Additions to computer software	(8,705)		(8,769)		(9,809)
Other, net	(3,940)		6,266		331
Cash (used for) provided by investing activities	(53,630)		80,073		(51,897)
Financing activities:
Proceeds from issuance of debt	574,900		155,100		—
Proceeds from issuance of common stock	—		189,971		—
Repayments of revolving credit facility, net	(103,200)		(74,700)		(32,200)
Repayments of debt	(553,140)		(617,271)		(85,592)
Financing costs paid	(13,912)		(10,367)		(4,313)
Cash dividends paid	(731)		(648)		(5,226)
Senior Notes make-whole premium paid	—		(4,980)		—
Payment for termination of interest rate swaps	(15,434)		—		—
Other, net	(17,961)		(16,491)		(2,866)
Cash used for financing activities	(129,478)		(379,386)		(130,197)
Effect of exchange rate changes on cash, cash equivalents and restricted cash	(3,540)		9,909		(2,671)
Net (decrease) increase in cash, cash equivalents and restricted cash	(62,471)		49,819		(18,680)
Cash, cash equivalents and restricted cash at beginning of year	134,506		84,687		103,367


	Common Shares Outstanding	Common Stock ($2 par value)		Paid-In Capital		Retained Earnings		Accumulated Other Comprehensive Loss		Total Equity
Balance, December 31, 2018	62,294	$	124,588	$	238,773	$	200,670	$	(45,612)	$	518,419
Net loss						(62,371)				(62,371)
Other comprehensive loss								(7,095)		(7,095)
Dividends declared ($0.01 per share)						(525)				(525)
Share-based compensation expense, exercises and other	549	1,098		12,628						13,726
Balance, December 31, 2019	62,843	125,686		251,401		137,774		(52,707)		462,154
Net income						29,871				29,871
Other comprehensive income								14,198		14,198
Dividends declared ($0.01 per share)						(623)				(623)
Issuance of common stock, net of issuance costs	9,746	19,493		170,478						189,971
Share-based compensation expense, exercises and other	883	1,765		14,718						16,483
Balance, December 31, 2020	73,472	146,944		436,597		167,022		(38,509)		712,054
Net income						221,589				221,589
Other comprehensive loss								(2,082)		(2,082)
Dividends declared ($0.01 per share)						(992)				(992)
Share-based compensation expense, exercises and other	1,961	3,921		4,011						7,932
Balance, December 31, 2021	75,433	$	150,865	$	440,608	$	387,619	$	(40,591)	$	938,501


December 31,	2021		2020
Land and land improvements	$	22,994	$	22,292
Buildings and leasehold improvements	171,268		155,576
Machinery and equipment	431,836		377,225
Construction in progress	25,637		44,695
Property and equipment, gross	651,735		599,788
Accumulated depreciation and amortization	(334,500)		(284,126)
Property and equipment, net	$	317,235	$	315,662


Summarized Consolidated Statement of Operations - Guarantor Group	For the year ended December 31, 2021
(Dollars in thousands)
Net revenue(1)	$	9,635,921
Gross margin	1,403,518
Operating income	316,725
Income from continuing operations, net of tax	193,303
Net income	193,303


Summarized Consolidated Balance Sheet - Guarantor Group	December 31, 2021
(Dollars in thousands)
Total current assets	$	1,449,917
Total assets	2,807,581
Current liabilities	1,399,499
Total liabilities	2,422,542


			Page
Consolidated Statements of Operations for the Years Ended December 31, 2021, 2020 and 2019			37
Consolidated Statements of Comprehensive Income (Loss) for the Years Ended December 31, 2021, 2020 and 2019			38
Consolidated Balance Sheets as of December 31, 2021 and 2020			39
Consolidated Statements of Cash Flows for the Years Ended December 31, 2021, 2020 and 2019			40
Consolidated Statements of Changes in Shareholders' Equity for the Years Ended December 31, 2021, 2020 and 2019			41
Notes to Consolidated Financial Statements			42
Report of Independent Registered Public Accounting Firm (KPMG, LLP, Richmond, VA, Auditor Firm ID: 185)			68


	December 31, 2021		December 31, 2020
Cash and cash equivalents	$	55,712	$	83,058
Restricted cash included in Other current assets	—		35,126
Restricted cash included in Other assets, net	16,323		16,322
Total cash, cash equivalents and restricted cash	$	72,035	$	134,506


	Global Solutions		Global Products		Consolidated
Net carrying amount of goodwill, December 31, 2019	$	283,905	$	109,276	$	393,181
Currency translation adjustments	—		905		905
Net carrying amount of goodwill, December 31, 2020	283,905		110,181		394,086
Currency translation adjustments	—		(6,717)		(6,717)
Acquisition	—		2,816		2,816
Net carrying amount of goodwill, December 31, 2021	$	283,905	$	106,280	$	390,185


	2021						2020
	Customer Relationships		Tradenames		Other Intangibles		Customer Relationships		Tradenames		Other Intangibles
Gross intangible assets	$	275,526	$	90,000	$	43,189	$	270,505	$	90,000	$	43,245
Accumulated amortization	(146,168)		(33,242)		(19,560)		(121,209)		(24,881)		(14,309)
Net intangible assets	$	129,358	$	56,758	$	23,629	$	149,296	$	65,119	$	28,936
Weighted average useful life	10 years		11 years		8 years		10 years		11 years		8 years


		Years ended December 31,
	Classification	2021		2020		2019
Operating lease cost	DS&A Expenses	$	59,397	$	53,675	$	53,588
Finance lease cost:
Amortization of lease assets	DS&A Expenses	1,098		963		1,322
Interest on lease liabilities	Interest expense, net	1,255		1,283		1,189
Total finance lease cost		2,353		2,246		2,511
Short-term lease cost	DS&A Expenses	871		1,081		348
Variable lease cost	DS&A Expenses	17,491		15,611		16,415
Total lease cost		$	80,112	$	72,613	$	72,862


		As of December 31,
	Classification	2021		2020
Assets:
Operating lease assets	Operating lease assets	$	194,006	$	144,755
Finance lease assets	Property and equipment, net	8,896		7,222
Total lease assets		$	202,902	$	151,977
Liabilities:
Current
Operating	Other current liabilities	$	41,817	$	33,412
Finance	Other current liabilities	2,037		1,085
Noncurrent
Operating	Operating lease liabilities, excluding current portion	162,241		119,932
Finance	Long-term debt, excluding current portion	11,314		10,124
Total lease liabilities		$	217,409	$	164,553


	Operating Leases		Finance Leases		Total
2022	$	58,460	$	2,731	$	61,191
2023	54,462		2,683		57,145
2024	47,166		2,630		49,796
2025	34,788		2,564		37,352
2026	23,692		2,248		25,940
Thereafter	35,046		5,533		40,579
Total lease payments	253,614		18,389		272,003
Less: Interest	(49,556)		(5,038)		(54,594)
Present value of lease liabilities	$	204,058	$	13,351	$	217,409


	Total
Accrued exit and realignment charges, December 31, 2018	$	7,477
Provision for exit and realignment activities:
Severance	6,008
Information system restructuring costs	2,531
Other	5,858
Cash payments	(13,712)
Accrued exit and realignment charges, December 31, 2019	8,162
Provision for exit and realignment activities:
Severance	5,623
Information system restructuring costs	2,119
Lease obligations	1,051
Other	6,519
Cash payments	(20,328)
Accrued exit and realignment charges, December 31, 2020	3,146
Provision for exit and realignment activities:
Severance	9,191
Information system restructuring costs	4,752
Lease obligations	440
Other	5,564
Cash payments	(14,787)
Accrued exit and realignment charges, December 31, 2021	$	8,306


Year
2022	$	3,627
2023	3,501
2024	3,372
2025	3,238
2026	3,084
2027-2031	13,210


				Derivative Assets			Derivative Liabilities
	Notional Amount		Maturity Date	Classification	Fair Value		Classification	Fair Value
Cash flow hedges
Interest rate swaps	$	300,000	May 2022 and May 2025	Other assets, net	$	—	Other liabilities	$	17,872

Economic (non-designated) hedges
Foreign currency contracts	$	30,300	January 2021	Other current assets	$	151	Other current liabilities	$	—


	Amount of Gain Recognized in Other Comprehensive Income (Loss)		Location of Loss Reclassified from Accumulated Other Comprehensive Loss into Income	Total Amount of Expense Line Items Presented in the Consolidated Statement of Operations in Which the Effects are Recorded		Amount of Gain (Loss) Reclassified from Accumulated Other Comprehensive Loss into Income
Interest rate swaps	$	2,426	Loss on extinguishment of debt	$	(40,433)	$	(25,518)


	Amount of Loss Recognized in Other Comprehensive Income		Location of Loss Reclassified from Accumulated Other Comprehensive Loss into Income	Total Amount of Expense Line Items Presented in the Consolidated Statement of Operations in Which the Effects are Recorded		Amount of Gain/(Loss) Reclassified from Accumulated Other Comprehensive Loss into Income
Interest rate swaps	$	(19,741)	Interest expense, net	$	(83,398)	$	(9,232)


	2021		2020
Unrecognized tax benefits at January 1,	$	20,770	$	11,520
Increases for positions taken during current period	858		1,488
Increases for positions taken during prior periods	2,422		9,073
Lapse of statute of limitations	(2,665)		(1,311)
Unrecognized tax benefits at December 31,	$	21,385	$	20,770


	Retirement Plans		Currency Translation Adjustments		Derivatives		Total
Accumulated other comprehensive loss, December 31, 2020	$	(18,447)	$	(18)	$	(20,044)	$	(38,509)
Other comprehensive income (loss) before reclassifications	4,462		(25,976)		2,426		(19,088)
Income tax	(1,428)		—		(611)		(2,039)
Other comprehensive income (loss) before reclassifications, net of tax	3,034		(25,976)		1,815		(21,127)
Amounts reclassified from accumulated other comprehensive loss	1,199		—		25,518		26,717
Income tax	(383)		—		(7,289)		(7,672)
Amounts reclassified from accumulated other comprehensive loss, net of tax	816		—		18,229		19,045
Other comprehensive income (loss)	3,850		(25,976)		20,044		(2,082)
Accumulated other comprehensive loss, December 31, 2021	$	(14,597)	$	(25,994)	$	—	$	(40,591)


2.1			Purchase Agreement, dated as of October 31, 2017, by and among Halyard Health, Inc., the other sellers party thereto and Owens & Minor, Inc. (incorporated herein by reference to our Current Report on Form 8-K/A, Exhibit 2.1, dated November 1, 2017) **

2.2			Amended and Restated Purchase Agreement, dated as of April 30, 2018, by and among Halyard Health, Inc., the other sellers party thereto and Owens & Minor, Inc. (incorporated herein by reference to our Current Report on Form 8-K, Exhibit 2.1, dated May 1, 2018)

2.3			Purchase Agreement, dated as of April 6, 2020 by and among EHDH Holding Group and Owens & Minor, Inc. (incorporated herein by reference to our Current Report on Form 8-K/A Exhibit 2.1, dated January 16, 2020)**

2.4			Agreement and Plan of Merger, dated as of January 7, 2022, by and among the Company, Apria and Merger Sub (incorporated herein by reference to the Company's Current Report on For 8-K, Exhibit 2.01, dated January 10, 2022)

3.1			Amended and Restated Articles of Incorporation of Owens & Minor, Inc. (incorporated herein by reference to our Current Report on Form 8-K, Exhibit 3.1, dated July 29, 2008)

3.2			Amended and Restated Bylaws of the Company effective January 31, 2022 (incorporated herein by reference to the Company’s Current Report on Form 8-K, Exhibit 3.1, dated January 31, 2022)

4.1			Indenture, dated September 16, 2014, by and among Owens & Minor, Inc., Owens and Minor Distribution, Inc., Owens & Minor Medical, Inc. and U.S. Bank National Association, as trustee (incorporated herein by reference to our Current Report on Form 8-K, Exhibit 4.1, dated September 17, 2014)

4.2			First Supplemental Indenture, dated September 16, 2014, by and among Owens & Minor, Inc., Owens and Minor Distribution, Inc., Owens & Minor Medical, Inc. and U.S. Bank National Association, as trustee (incorporated herein by reference to our Current Report on Form 8-K, Exhibit 4.2, dated September 17, 2014)

4.3			Form of Global Note for the 3.875% Senior Notes due 2021 (incorporated herein by reference to our Current Report on Form 8-K, Exhibit A of Exhibit 4.2, dated September 17, 2014)

4.4			Form of Global Note for the 4.375% Senior Notes due 2024 (incorporated herein by reference to our Current Report on Form 8-K, Exhibit B of Exhibit 4.2, dated September 17, 2014)

4.5			Third Supplemental Indenture, dated as of April 30, 2018, by and among Owens & Minor, Inc., the guarantors signatory thereto and U.S. Bank National Association, as trustee. (incorporated herein by reference to our Current Report on Form 8-K, Exhibit 4.1, dated May 4, 2018)

4.6			Fourth Supplemental Indenture, dated as of February 12, 2019, among Owens & Minor, Inc., the guarantors signatory thereto and U.S. Bank National Association, as trustee. (incorporated herein by reference to our Current Report on Form 8-K, Exhibit 4.1, dated February 19, 2019)

4.7			Indenture, dated March 10, 2021, among Owens & Minor, Inc., the guarantors named therein and Regions Bank, as Trustee (incorporated herein by reference to the Company’s Current Report on Form 8-K, Exhibit 4.1, dated March 11, 2021)

4.8			Form of Global Note for the 4.500% Senior Notes due 2029 (included as Exhibit A to Exhibit 4.1 hereto) (incorporated herein by reference to the Company’s Current Report on Form 8-K, Exhibit 4.2, dated March 11, 2021)

4.9			Sixth Supplemental Indenture, dated as of March 10, 2021, by and among Owens & Minor, Inc., the guarantors signatory thereto and U.S. Bank National Association, as trustee (incorporated herein by reference to the Company’s Current Report on Form 8-K, Exhibit 4.3, dated March 11, 2021).

4.10			Description of Securities - filed herewith

10.1			Form of Director Restricted Stock Agreement under the 2015 Plan (incorporated herein by reference to our Quarterly Report on Form 10-Q, Exhibit 10.3, for the quarter ended March 31, 2016)*


10.2			Form of Owens & Minor, Inc. Restricted Stock Agreement under the 2018 Stock Incentive Plan effective February 28, 2019 (incorporated herein by reference to our Current report on 8-K, Exhibit 10.1, dated March 1, 2019)*

10.3			Owens & Minor, Inc. Directors’ Deferred Compensation Plan, as amended and restated effective January 1, 2005 (incorporated herein by reference to our Quarterly Report on Form 10-Q, Exhibit 10.3, for the quarter ended September 30, 2008)*

10.4			Form of Owens & Minor, Inc. Executive Severance Agreement effective January 1, 2011 (incorporated herein by reference to our Annual Report on Form 10-K, Exhibit 10.10, for the year ended December 31, 2010)*

10.5			Form of Owens & Minor, Inc. Executive Change in Control Severance Agreement between Owens & Minor, Inc. and Edward A. Pesicka effective March 4, 2019 (incorporated herein by reference to our Current Report on Form 8-K, Exhibit 10.1, dated February 25, 2019)*

10.6			Form of Owens & Minor, Inc. Executive Change in Control Severance Agreement effective October 25, 2018 (incorporated herein by reference to our Annual Report on Form 10-K, Exhibit 10.7, for the year ended December 31, 2018)*

10.7			Owens & Minor, Inc. Supplemental Executive Retirement Plan, as amended and restated effective January 1, 2005 (“SERP”) (incorporated herein by reference to our Quarterly Report on Form 10-Q, Exhibit 10.1, for the quarter ended September 30, 2008)*

10.8			Resolutions of the Board of Directors of the Company amending the SERP (incorporated herein by reference to our Annual Report on Form 10-K, Exhibit 10.12, for the year ended December 31, 2011)*

10.9			Amendment effective March 1, 2016 of the Company’s SERP (incorporated herein by reference to our Quarterly Report on Form 10-Q, Exhibit 10.6, for the quarter ended March 31, 2016)*

10.10			Amendment effective March 1, 2016 of Exhibit II of the Company’s SERP (incorporated herein by reference to our Quarterly Report on Form 10-Q, Exhibit 10.7, for the quarter ended March 31, 2016)*

10.11			Owens & Minor, Inc. Amended and Restated Management Equity Ownership Program and Stock Ownership Rewards Program (incorporated herein by reference to our Annual Report on Form 10-K, Exhibit 10.15, for the year ended December 31, 2009)*

10.12			Amendment to MEOP effective January 1, 2014 (incorporated herein by reference to our Annual Report on Form 10-K, Exhibit 10.10, for the year ended December 31, 2013)*

10.13			Owens & Minor, Inc. Executive Deferred Compensation and Retirement Plan effective January 1, 2013 (incorporated herein by reference to our Quarterly Report on Form 10-Q, Exhibit 10.1, for the quarter ended March 31, 2013)*

10.14			Form of Owens & Minor, Inc. Restricted Stock Agreement under the 2015 Stock Incentive Plan (incorporated herein by reference to our Quarterly Report on Form 10-Q, Exhibit 10.2, for the quarter ended March 31, 2016)*

10.15			Form of Owens & Minor, Inc. Restricted Stock Unit Agreement under the Company’s 2015 Stock Incentive Plan (incorporated herein by reference to our Quarterly Report on Form 10-Q, Exhibit 10.1, for the quarter ended March 31, 2016)*

10.16			Form of Owens & Minor Director Restricted Stock Agreement under the Company’s 2018 Stock Incentive Plan (incorporated herein by reference to our Current Report on Form 8-K, Exhibit 10.1, dated May 9, 2018)*

10.17			Form of Owens & Minor Restricted Stock Agreement under the Company’s 2018 Stock Incentive Plan (incorporated herein by reference to our Current Report on Form 8-K, Exhibit 10.2, dated May 9, 2018)*

10.18			Form of Owens & Minor Restricted Stock Unit Agreement under the Company’s 2018 Stock Incentive Plan (incorporated herein by reference to our Current Report on Form 8-K, Exhibit 10.3, dated May 9, 2018)*

10.19			Form of 2016 Performance Share Award Agreement under the 2015 Stock Incentive Plan (incorporated herein by reference to our Quarterly Report on Form 10-Q, Exhibit 10.4, for the quarter ended March 31, 2016)*

10.20			Form of Owens & Minor, Inc. 2019 Performance Share Award Agreement under the 2018 Stock Incentive Plan (incorporated herein by reference to our Current report on 8-K, Exhibit 10.2, dated March 1, 2019)*


10.21			Form of Owens & Minor, Inc. 2020 Performance Share Award Agreement under the 2018 Stock Incentive Plan (incorporated herein by reference to our Current report on 8-K, Exhibit 10.2, dated May 1, 2020)*

10.22			Owens & Minor, Inc. Officer Severance Policy dated May 7, 2018 (incorporated herein by reference to our Current Report on Form 8-K, Exhibit 10.4, dated May 9, 2018)*

10.23			Policy on Recoupment of Executive Incentive Compensation (incorporated herein by reference to our Annual Report on Form 10-K, Exhibit 10.36, for the year ended December 31, 2009)*

10.24			Owens & Minor, Inc. 2015 Stock Incentive Plan (incorporated herein by reference to our Registration Statement on Form S-8, Registration Number 333-203826)*

10.25			Owens & Minor, Inc. 2018 Stock Incentive Plan (incorporated herein by reference to our Registration Statement on Form S-8, Registration number 333-224787)*

10.26			Credit Agreement dated as of June 5, 2012 by and among Owens & Minor Distribution, Inc. and Owens & Minor Medical, Inc. (as Borrowers), Owens & Minor, Inc. and certain of its domestic subsidiaries (as Guarantors), Wells Fargo Bank, N.A. (as Administrative Agent), JPMorgan Chase Bank, N.A. (as Syndication Agent) and a syndicate of banks as specified on the signature pages thereof (incorporated herein by reference to our Current Report on Form 8-K, Exhibit 10.1, dated June 8, 2012)

10.27			First Amendment dated as of September 17, 2014 by and among Owens & Minor Distribution, Inc. and Owens & Minor Medical, Inc. ( as Borrowers), Owens & Minor, Inc. and certain of its domestic subsidiaries (as Guarantors) and Wells Fargo Bank, N.A. ( as Administrative Agent), to the Credit Agreement dated as of June 5, 2012 by and among the Borrowers, the Guarantors, a syndicate of financial institutions party thereto, the Administrative Agent, and the other agents party thereto (incorporated herein by reference to our Current Report on Form 8-K, Exhibit 10.1, dated September 18, 2014)

10.28			Interest Purchase Agreement, dated as of May 2, 2017, by and among Owens & Minor, Inc., Barista Acquisition I, LLC, Barista Acquisition II, LLC , Mediq B.V. , Mediq International B.V. and Mediq USA Holdings (incorporated herein by reference to our Quarterly Report on Form 10-Q, Exhibit 10.1, for the quarter ended March 31, 2017)

10.29			Owens & Minor, Inc. 2017 Teammate Stock Purchase Plan (incorporated by reference to Appendix A to the Company’s Definitive Proxy Statement on Schedule 14A filed March 22, 2017 (File No. 001-09810))*

10.30			Credit Agreement, dated as of July 27, 2017, by and among Owens & Minor Distribution, Inc., Owens & Minor Medical, Inc., Barista Acquisition I, LLC, and Barista Acquisition II, LLC, (the “Borrowers”), Owens & Minor, Inc. and certain of its domestic subsidiaries (together, the “Guarantors), Merrill Lynch, Pierce, Fenner & Smith Incorporated, and Wells Fargo Bank, N.A. (the “Administrative Agent”), a syndicate of financial institutions party thereto, and the other agents party thereto (incorporated herein by reference to our Current Report on Form 8-K, Exhibit 10.1, dated July 28, 2017)

10.31			Restated Guaranty Agreement, dated as of the February 12, 2019, by and among Owens & Minor, Inc., the other Guarantors party thereto and Bank of America, N.A., as administrative agent for the Pro Rata Facilities and the Term B Facility (incorporated herein by reference to our Current Report on Form 8-K, Exhibit 10.1, dated February 19, 2019)

10.32			Security and Pledge Agreement, dated as of April 30, 2018, by and among Owens & Minor, Inc., O&M Halyard, Inc., Owens & Minor Distribution, Inc., Owens & Minor Medical, Inc., Barista Acquisition I, LLC and Barista Acquisition II, LLC, Bank of America, N.A., U.S. Bank National Association, and the other secured parties thereto. (incorporated herein by reference to our Current Report on Form 8-K, Exhibit 10.2, dated May 4, 2018)

10.33			First Amendment to Credit Agreement, dated as of March 29, 2018, by and among Owens & Minor Distribution, Inc., Owens & Minor Medical, Inc., Barista Acquisition I, LLC, and Barista Acquisition II, LLC, as Borrowers, Owens & Minor, Inc. and certain of its domestic subsidiaries, as Guarantors, the banks party thereto and Wells Fargo Bank, N.A., as Administrative Agent for the banks party thereto (incorporated herein by reference to our Current Report on Form 8-K/A, Exhibit 10.1, dated April 18, 2018)

10.34			Second Amendment to Credit Agreement, dated as of April 30, 2018, by and among O&M Halyard, Inc., Owens & Minor Distribution, Inc., Owens & Minor Medical, Inc., Barista Acquisition I, LLC and Barista Acquisition II, LLC, Owens & Minor, Inc. and each other domestic subsidiary of the Company party thereto from time to time, Wells Fargo Bank, N.A., as administrative agent for certain of the credit facilities, Bank of America, N.A., as collateral agent and administrative agent for the term B facility, and the other agents party thereto. (incorporated herein by reference to our Current Report on Form 8-K, Exhibit 10.1, dated May 4, 2018)


10.35			Third Amendment to Credit Agreement, dated as of May 9, 2018, by and among O&M Halyard, Inc., Owens & Minor Distribution, Inc., Owens & Minor Medical, Inc., Barista Acquisition I, LLC and Barista Acquisition II, LLC, Owens & Minor, Inc. and each other domestic subsidiary of the Company party thereto from time to time, Wells Fargo Bank, N.A., as administrative agent for certain of the credit facilities, Bank of America, N.A., as collateral agent and administrative agent for the term B facility, and the other agents party thereto. (incorporated herein by reference to our Form 10-Q, Exhibit 10.9, dated May 10, 2018)

10.36			Fourth Amendment to Credit Agreement, dated as of February 12, 2019, by and among O&M Halyard, Inc., Owens & Minor Distribution, Inc., Owens & Minor Medical, Inc., Barista Acquisition I, LLC and Barista Acquisition II, LLC, Owens & Minor, Inc. and each other domestic subsidiary of the Company party thereto from time to time, Bank of America, N.A., as administrative agent for certain of the credit facilities and as collateral agent and administrative agent for the term B facility, and the other agents party thereto. (incorporated herein by reference to our Current Report on Form 8-K, Exhibit 10.1, dated February 19, 2019)

10.37			Amendment to the Owens & Minor, Inc. 2018 Stock Incentive Plan (Incorporated herein by reference to our Current Report on Form 8-K, Exhibit 10.1, dated May 10, 2019*

10.38			Owens & Minor, Inc. Directors’ Deferred Compensation Plan, as Amended and Restated Effective May 10, 2019 ((Incorporated herein by reference to our Current Report on Form 8-K, Exhibit 10.2, dated May 10, 2019*

10.39			Fifth Amendment to Credit Agreement, dated as of February 13, 2020, by and among O&M Halyard, Inc., Owens & Minor Distribution, Inc., Owens & Minor Medical, Inc., Barista Acquisition I, LLC and Barista Acquisition II, LLC, Owens & Minor, Inc. and each other domestic subsidiary of the Company party thereto from time to time, Bank of America, N.A., as administrative agent for certain of the credit facilities and as collateral agent and administrative agent for the term B facility, and the other agents party thereto. (Incorporated herein by reference to our Current Report on Form 8-K, Exhibit 10.1, dated February 18, 2020)

10.40			Receivables Financing Agreement, dated as of February 19, 2020, by and among Owens & Minor Medical, Inc., as the initial servicer, O&M Funding LLC, as borrower, the lenders from time to time party thereto, PNC Bank, National Association, as administrative agent, and PNC Capital Markets LLC, as structuring agent. (Incorporated herein by reference to our Current Report on Form 8-K, Exhibit 10.1, dated February 19, 2020)

10.41			Purchase and Sale Agreement, dated as of February 19, 2020, by and among Owens & Minor Distribution, Inc., as the originator, Owens & Minor Medical, Inc., as servicer, and O&M Funding LLC, as buyer. (Incorporated herein by reference to our Current Report on Form 8-K, Exhibit 10.2, dated February 19, 2020)

10.42			Performance Guaranty of Owens & Minor, Inc., dated as of February 19, 2020 in favor of PNC Bank, National Association. (Incorporated herein by reference to our Current Report on Form 8-K, Exhibit 10.3, dated February 19, 2020)

10.43			Amendment No. 2 to the Owens & Minor, Inc. 2018 Stock Incentive Plan (incorporated by reference to Appendix A to the Company’s Definitive Proxy Statement on Schedule 14A filed March 19, 2020. (File No. 001-09810))*

10.44			First Amendment to the Receivables Financing Agreement, dated as of May 19, 2020, by and among Owens & Minor Medical, Inc., as the initial servicer, O&M Funding LLC, as borrower, the lenders from time to time party thereto, PNC Bank, National Association, as administrative agent, and PNC Capital Markets LLC, as structuring agent (incorporated herein by reference to our Quarterly Report on Form 10-Q, Exhibit 10.1, for the quarter ended June 30, 2020)

10.45			Second Amendment to the Receivables Financing Agreement, dated as of July 1, 2020, by and among Owens & Minor Medical, Inc., as the initial servicer, O&M Funding LLC, as borrower, the lenders from time to time party thereto, PNC Bank, National Association, as administrative agent, and PNC Capital Markets LLC, as structuring agent (incorporated herein by reference to our Quarterly Report on Form 10-Q, Exhibit 10.2, for the quarter ended June 30, 2020)

10.46			Form of Restricted Stock Agreement (incorporated herein by reference to the Company’s Current Report on Form 8-K, Exhibit 10.1, dated February 26, 2021)*

10.47			Form of Restricted Stock Unit Award Agreement (incorporated herein by reference to the Company’s Current Report on Form 8-K, Exhibit 10.2, dated February 26, 2021)*

10.48			Form of 2021 Performance Stock Unit Award Agreement (incorporated herein by reference to the Company’s Current Report on Form 8-K, Exhibit 10.3, dated February 26, 2021)*